Data / Research funding / Parkinson's Disease
Parkinson's Disease: 854 NIH awards ($952.4M) to 209 organizations
854 NIH awards ($952.4M) in the NIH spending category Parkinson's Disease, to 209 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 854 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Prevention of Fractures in Patients with Parkinson's Disease | NIH | National Institute on Aging | 2022 to 2024 | $13,269,734 | September 30, 2018 | February 28, 2026 | CUMMINGS, STEVEN RON | reporter.nih.gov |
| Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,006,073 | September 25, 2019 | July 31, 2026 | CORCOS, DANIEL M. | reporter.nih.gov |
| Parkinsons Disease Scalable iPSC Autologous Cell Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,528,144 | January 1, 2020 | December 31, 2025 | HALLETT, PENELOPE JANE | reporter.nih.gov |
| Dementia with Lewy Bodies Consortium | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $6,563,373 | September 30, 2016 | August 31, 2027 | LEVERENZ, JAMES BRUCE | reporter.nih.gov |
| Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,598,826 | May 1, 2021 | April 30, 2029 | KRAINC, DIMITRI | reporter.nih.gov |
| Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $4,943,234 | September 15, 2022 | June 30, 2027 | SEYFRIED, NICHOLAS THOMAS | reporter.nih.gov |
| Web-based Automated Imaging Differentiation of Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,837,150 | April 1, 2021 | March 31, 2027 | VAILLANCOURT, DAVID E | reporter.nih.gov |
| Achieving specificity in imaging neurodegeneration with visible light Optical Coherence Tomography | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,798,178 | September 15, 2024 | September 14, 2027 | SRINIVASAN, VIVEK JAY | reporter.nih.gov |
| Structural Biology of Alpha-Synuclein in Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $4,231,530 | September 30, 2018 | August 31, 2026 | KOTZBAUER, PAUL T | reporter.nih.gov |
| Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $4,228,325 | May 1, 2019 | March 31, 2025 | SAUNDERS-PULLMAN, RACHEL | reporter.nih.gov |
| Toxicant-induced neurotoxicity mediated by glia-neuron and gene-environment interactions in Parkinson's disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $4,217,249 | June 1, 2019 | April 30, 2027 | TIEU, KIM | reporter.nih.gov |
| Peripheral Tissue Biomarker for Premortem Diagnosis of Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $4,170,328 | December 15, 2021 | June 30, 2026 | CHEN, SHU G. | reporter.nih.gov |
| Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease: An Investigation of STN LFP Biomarkers in Sleep Dysregulation and Repair | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,098,597 | February 17, 2025 | June 30, 2026 | ABOSCH, AVIVA | reporter.nih.gov |
| Neuro-exergaming for the Prevention and Remediation of Decline due to Parkinson's Disease: Clinical Trial of the Interactive Physical and Cognitive Exercise System (iPACES v3) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $4,081,293 | August 11, 2023 | July 31, 2027 | GILLEN, ROBERT WILLSON | reporter.nih.gov |
| Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $3,985,569 | June 1, 2019 | May 31, 2025 | MAILMAN, RICHARD B | reporter.nih.gov |
| Skin biomarkers for diagnosing and characterizing AD and ADRD | NIH | National Institute on Aging | 2021 to 2025 | $3,834,262 | September 30, 2021 | June 30, 2027 | KRAUS, ALLISON L | reporter.nih.gov |
| Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,826,830 | August 1, 2015 | June 30, 2027 | SINGER, WOLFGANG | reporter.nih.gov |
| Elucidating the Biological Differences Between Distinct Fibrillar and Non-Fibrillar Alpha-Synuclein Inclusions in Human Stem-Cell Models | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,706,946 | July 1, 2020 | April 30, 2026 | KHURANA, VIKRAM | reporter.nih.gov |
| Neurotoxic and neurodegenerative risks from chronic exposure to metal mixtures in e-cigarette aerosol | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,656,277 | September 8, 2021 | June 30, 2027 | RE, DIANE BERENGERE | reporter.nih.gov |
| Basal Ganglia Cortical Coupling and Connectivity Changes in PD and DBS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,646,454 | July 1, 1999 | January 31, 2029 | VITEK, JERROLD L | reporter.nih.gov |
| IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD) | NIH | National Institute on Aging | 2024 to 2025 | $3,640,661 | June 5, 2024 | May 31, 2029 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait using Neural and Kinematic Feedback | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $3,624,489 | August 1, 2019 | July 31, 2025 | BRONTE-STEWART, HELEN | reporter.nih.gov |
| Determinants of Basal Ganglia Pathology in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,599,326 | April 15, 2021 | March 31, 2027 | SURMEIER, DALTON JAMES | reporter.nih.gov |
| Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,568,423 | July 15, 2021 | May 31, 2027 | ZHAO, GUOYAN | reporter.nih.gov |
| Region-Specific Vulnerability of the Lewy Body Dementia's Brain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,557,900 | August 1, 2021 | June 30, 2027 | NA, CHAN-HYUN | reporter.nih.gov |
| Advanced MRI studies of cerebrovascular and lymphatic abnormalities in LRRK2 mouse models of Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,536,285 | April 1, 2021 | March 31, 2027 | SMITH, WANLI W | reporter.nih.gov |
| Investigating neuroanatomical underpinnings of apathy in ADRD through neuroimaging and electrical manipulation | NIH | National Institute of Mental Health | 2021 to 2025 | $3,513,225 | July 1, 2021 | June 30, 2027 | VANEGAS-ARROYAVE, NORA | reporter.nih.gov |
| More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease and Lewy Body Dementias | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,433,868 | September 15, 2016 | September 30, 2026 | KLUGER, BENZI M | reporter.nih.gov |
| Preclinical development of a novel therapeutic for Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,421,621 | September 30, 2021 | May 31, 2025 | BORDBAR, AARASH | reporter.nih.gov |
| Modeling functional genomics of susceptibility to the persistent effects of environmental toxins in an elderly rural Indiana neurodegenerative cohort | NIH | National Institute on Aging | 2022 to 2025 | $3,385,412 | September 15, 2022 | May 31, 2027 | BOWMAN, AARON B | reporter.nih.gov |
| Deciphering innate immune signaling mechanisms in glial cells linking lifetime environmental exposures to neuroinflammation, protein aggregation and neurodegeneration in Parkinsons disease | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $3,351,160 | June 12, 2023 | March 31, 2031 | TJALKENS, RONALD | reporter.nih.gov |
| The Role of Myeloid Cells in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,311,240 | April 1, 2021 | June 30, 2026 | RAJ, TOWFIQUE | reporter.nih.gov |
| Preclinical trial for dysarthria treatment in Parkinson disease | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,266,069 | December 1, 2020 | November 30, 2025 | CIUCCI, MICHELLE RENEE | reporter.nih.gov |
| A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB) | NIH | National Institute on Aging | 2021 to 2022 | $3,210,062 | July 1, 2019 | April 30, 2025 | MOUSSA, CHARBEL | reporter.nih.gov |
| Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson's Disease Trials-2 (AT-HOME PD-2) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $3,209,104 | May 1, 2023 | April 30, 2028 | SCHNEIDER, RUTH | reporter.nih.gov |
| Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,203,281 | April 1, 2021 | March 31, 2027 | STUDER, LORENZ P. | reporter.nih.gov |
| LRRK2 and inflammasome pathway in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,192,206 | July 1, 2021 | June 30, 2027 | SMITH, WANLI W | reporter.nih.gov |
| Spatial organization and conformational ensembles of amyloids inside cells | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,178,675 | August 13, 2025 | July 31, 2029 | FREDERICK, KENDRA KING | reporter.nih.gov |
| Deep Phenotypic Characterization of Prodromal Dementia with Lewy Bodies | NIH | National Institute on Aging | 2022 | $3,171,435 | September 30, 2022 | August 31, 2025 | GALVIN, JAMES E | reporter.nih.gov |
| ENIGMA Parkinson’s Initiative: A Global Initiative for Parkinson’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,159,326 | September 1, 2021 | August 31, 2026 | THOMPSON, PAUL M | reporter.nih.gov |
| Microbiome, Environment, and Parkinsons disease (MEP) PESTICIDE EXPOSURES AND THE GUT MICROBIOME IN PARKINSONS DISEASE | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,143,396 | August 15, 2020 | June 30, 2026 | RITZ, BEATE R. | reporter.nih.gov |
| Visual hallucinations and memory impairment in Parkinson's Disease: The role of hippocampal networks | NIH | National Institute of Mental Health | 2021 to 2025 | $3,119,615 | September 1, 2021 | June 30, 2027 | BAKKER, ARNOLD | reporter.nih.gov |
| Pesticides, Olfaction, and Neurodegeneration Among US Farmers | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $3,108,694 | February 1, 2019 | January 31, 2025 | CHEN, HONGLEI | reporter.nih.gov |
| Neurophysiological Mechanisms Underlying Parkinsonian Motor Signs | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,106,163 | August 1, 2021 | June 30, 2027 | VITEK, JERROLD L | reporter.nih.gov |
| Preclinical Markers of Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,073,020 | August 1, 2021 | June 30, 2027 | VAILLANCOURT, DAVID E | reporter.nih.gov |
| Production and Distribution of well-characterized polymorphic variants of alpha-synuclein aggregates | NIH | National Institute on Aging | 2022 to 2025 | $3,065,392 | September 30, 2022 | May 31, 2027 | SOTO, CLAUDIO | reporter.nih.gov |
| Anxiety and depression in a nonhuman primate model of synucleinopathy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,064,072 | August 4, 2025 | July 31, 2029 | EMBORG, MARINA | reporter.nih.gov |
| Central cholinergic presbyvestibulopathy network changes and imbalance in Parkinson's disease and older persons | NIH | National Institute on Aging | 2021 to 2025 | $3,043,334 | September 30, 2021 | May 31, 2027 | BOHNEN, NICOLAAS IDA | reporter.nih.gov |
| Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $3,000,000 | September 15, 2022 | August 31, 2025 | LEVINE, TODD | reporter.nih.gov |
| Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,977,682 | September 23, 2021 | August 31, 2024 | SARRAF, STELLA | reporter.nih.gov |
| Single-Nuclei Multiomic Analysis of DLB Progression | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,970,479 | August 17, 2022 | July 31, 2027 | KIM, YOON-SEONG | reporter.nih.gov |
| Targeted Pathway Activation for PosturalInstability and Gait Disorder in Parkinson'sDisease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,952,277 | July 15, 2022 | June 30, 2027 | COOPER, SCOTT E | reporter.nih.gov |
| The effects of parkinsonism and deep brain stimulation on basal ganglia-thalamocortical circuitry during sleep-wake behavior | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,950,204 | July 1, 2024 | March 31, 2029 | JOHNSON, LUKE AARON | reporter.nih.gov |
| Systematic Study of Extracellular Vesicles and their Integrative Analysis with Parkinson's Organoids MAP | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,931,350 | April 15, 2022 | March 31, 2027 | LEE, LUKE P. | reporter.nih.gov |
| Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,919,989 | September 23, 2022 | August 31, 2026 | EITAN, EREZ | reporter.nih.gov |
| Brainstem-based imaging biomarkers of premanifest synucleinopathy | NIH | National Institute on Aging | 2021 to 2024 | $2,913,904 | May 15, 2020 | April 30, 2026 | BIANCIARDI, MARTA | reporter.nih.gov |
| Structural basis and physiological consequences of alpha-Synuclein binding to neurexin 1beta | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,894,995 | July 1, 2021 | June 30, 2027 | RHOADES, ELIZABETH | reporter.nih.gov |
| Rehabilitation of Airway Protection in Parkinson's Disease: Comparing In-Person and Telehealth Service Delivery Models | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,857,687 | September 1, 2022 | July 31, 2026 | TROCHE, MICHELLE S | reporter.nih.gov |
| Modeling and Mapping Human Action Regulation Networks | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,819,210 | August 15, 2023 | June 30, 2028 | POURATIAN, NADER | reporter.nih.gov |
| An Integrated Biomarker Approach to Personalized, Adaptive Deep Brain Stimulation in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,778,905 | February 15, 2023 | January 31, 2027 | TURNER, DENNIS ALAN | reporter.nih.gov |
| Genetic Analysis of Neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,737,431 | May 1, 2023 | April 30, 2031 | FEANY, MEL B | reporter.nih.gov |
| Simultaneous PET/phMR studies on interplay of mGlu/dopamine receptors in PD-like neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,725,861 | July 1, 2022 | June 30, 2027 | BROWNELL, ANNA-LIISA | reporter.nih.gov |
| Vitamin K and D and Cognitive Impairment in Older Adults | NIH | National Institute on Aging | 2022 to 2025 | $2,723,572 | September 1, 2016 | March 31, 2027 | BOOTH, SARAH LOUISE | reporter.nih.gov |
| Vesicular modulation of dopamine neuron toxicity | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,681,001 | November 17, 2014 | December 31, 2026 | MILLER, GARY W | reporter.nih.gov |
| A Computational Approach for Quantifying Motor Behaviors in Spinocerebellar Ataxias to Improve Early Detection of Motor Signs and Precisely Estimate Disease Severity and Disease Change | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,671,482 | April 15, 2021 | March 31, 2027 | GUPTA, ANOOPUM SATYAWAN | reporter.nih.gov |
| Identifying novel Parkinson'Âs disease genes exploring understudied Latino populations | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,667,664 | August 1, 2020 | July 31, 2025 | FERNANDEZ MATA, IGNACIO | reporter.nih.gov |
| Mechanisms of LRRK2 Mediated Neurotoxicity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,663,129 | September 1, 2010 | June 30, 2026 | WEST, ANDREW B | reporter.nih.gov |
| Circuit-specific, chemogenetic neuromodulation in nonhuman primates. | NIH | National Institute of Mental Health | 2023 to 2024 | $2,658,871 | June 15, 2023 | April 30, 2026 | SCHROEDER, CHARLES E | reporter.nih.gov |
| MULTIMODAL MRI TO PREDICT DBS MOTOR AND COGNITIVE OUTCOMES IN PARKINSON’S DISEASE | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,639,613 | September 19, 2022 | August 31, 2027 | MORRISON, MELANIE A | reporter.nih.gov |
| Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,637,479 | August 1, 2023 | July 31, 2028 | RYMAN, SEPHIRA | reporter.nih.gov |
| The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,609,788 | September 20, 2019 | August 31, 2025 | POSTON, KATHLEEN LOMBARD | reporter.nih.gov |
| Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and Genetics | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,609,599 | April 1, 2022 | March 31, 2027 | HALL, DEBORAH A | reporter.nih.gov |
| Neuronal Activity in MC and SMA during STN and GPi DBS in the Parkinsonian Monkey | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,604,080 | August 15, 2012 | July 31, 2025 | VITEK, JERROLD L | reporter.nih.gov |
| Biomarker discovery for parkinsonian diseases in extracellular vesicles from iPSC-derived neurons | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $2,555,369 | April 1, 2023 | March 31, 2026 | BITAN, GAL | reporter.nih.gov |
| Neurostimulation of the Nucleus Basalis of Meynert for the cognitive-motor syndrome in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $2,549,857 | August 19, 2022 | July 31, 2027 | BRONTE-STEWART, HELEN | reporter.nih.gov |
| Citalopram as a posterior cortical protective therapy in Parkinson disease | NIH | National Institute on Aging | 2021 to 2024 | $2,545,093 | August 15, 2020 | April 30, 2026 | KOTAGAL, VIKAS | reporter.nih.gov |
| Acquisition of a FLUOstar Omega plate reader | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,541,466 | May 1, 2020 | April 30, 2026 | BAUM, JEAN S | reporter.nih.gov |
| Interrogating Maladaptive Serotonin Raphe-Striatal Plasticity in L-DOPA-Induced Dyskinesia | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,540,892 | December 1, 2021 | November 30, 2026 | BISHOP, CHRISTOPHER R | reporter.nih.gov |
| Role of Glutamatergic Neurons in External Globus Pallidus in the Behavioral Deficits in Animal Models of Progressive Dopamine Depletion | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,533,610 | September 2, 2021 | June 30, 2027 | LIM, BYUNGKOOK | reporter.nih.gov |
| Multi-tissue High-throughput Proteomic and Genomic Study in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,522,438 | September 30, 2020 | August 31, 2026 | BENITEZ, BRUNO | reporter.nih.gov |
| Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,493,768 | August 1, 2023 | July 31, 2028 | KHURANA, VIKRAM | reporter.nih.gov |
| The role of a-synuclein accumulation in lysosomal hydrolase trafficking and function | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,474,168 | August 1, 2015 | April 30, 2027 | MAZZULLI, JOSEPH R | reporter.nih.gov |
| Characterizing the link between multiple environmental exposures and Parkinsons disease exacerbation | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,467,032 | September 20, 2022 | July 31, 2026 | ZANOBETTI, ANTONELLA | reporter.nih.gov |
| Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat | NIH | National Institute on Aging | 2023 to 2025 | $2,463,125 | May 1, 2023 | March 31, 2028 | GOMPERTS, STEPHEN N. | reporter.nih.gov |
| Optimizing coordinated reset deep brain stimulation for Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,462,398 | September 30, 2020 | June 30, 2026 | WANG, JING | reporter.nih.gov |
| Role of Subthalamic nucleus in Speech and Movement among people with Parkinson’s as Revealed by Intraoperative Recordings and Deep Brain Stimulation | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,436,687 | July 1, 2020 | June 30, 2025 | GREENLEE, JEREMY | reporter.nih.gov |
| Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,430,578 | September 30, 2020 | August 31, 2025 | SANDERS, LAURIE H | reporter.nih.gov |
| Digital Markers of Mobility in Daily Life to Track Progression in Newly Diagnosed Parkinson's Disease | NIH | National Institute on Aging | 2022 to 2025 | $2,430,381 | September 30, 2022 | May 31, 2027 | MANCINI, MARTINA | reporter.nih.gov |
| Quantitative Imaging of Brain Glymphatic Function in Humans | NIH | National Institute on Aging | 2021 to 2024 | $2,426,232 | April 15, 2020 | February 28, 2026 | DONAHUE, MANUS J | reporter.nih.gov |
| Comprehensive Augmented Reality Testing (CART) Platform for Parkinson’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,416,358 | September 1, 2022 | July 31, 2027 | ALBERTS, JAY L. | reporter.nih.gov |
| Spatiotemporal Optimization of Deep Brain Stimulation for Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,413,709 | July 15, 2016 | June 30, 2027 | JOHNSON, MATTHEW DOUGLAS | reporter.nih.gov |
| Neurofunctional Mechanisms of Changes in Cognition and Motor Function in Aging with HIV and Parkinson's Disease | NIH | National Institute on Aging | 2023 to 2025 | $2,413,140 | May 15, 2023 | April 30, 2028 | SCHULTE, TILMAN | reporter.nih.gov |
| Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreadingof neurodegenerative disease | NIH | National Institute on Aging | 2021 to 2024 | $2,409,422 | May 1, 2020 | February 28, 2026 | LEE, JIN HYUNG | reporter.nih.gov |
| TMEM106B in neurodegenerative disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,390,842 | July 15, 2013 | February 28, 2025 | CHEN-PLOTKIN, ALICE S | reporter.nih.gov |
| Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,385,538 | September 15, 2017 | February 28, 2024 | SVENDSEN, CLIVE NIELS | reporter.nih.gov |
| Dissecting the Etiology of The Lewy Body Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,383,188 | May 1, 2022 | April 30, 2025 | FINKBEINER, STEVEN M | reporter.nih.gov |
| Immunologic and Imaging studies with TNF Therapy in Prodromal Synucleinopathies | NIH | National Institute on Aging | 2025 | $2,361,361 | September 1, 2025 | August 31, 2030 | CEDARBAUM, JESSE | reporter.nih.gov |
| Developmental underpinnings of substantia nigra vulnerability | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,358,716 | January 1, 2021 | December 31, 2026 | AWATRAMANI, RAJESHWAR B | reporter.nih.gov |
| The Impact of Beta- and Gamma-synucleins on Alpha-synuclein's Synaptic Function | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $2,342,275 | May 1, 2023 | March 31, 2024 | BURRE, JACQUELINE | reporter.nih.gov |
| Neuroplasticity and the emergence of motor and cognitive deficits in prodromal synucleinopathy | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,336,166 | August 15, 2022 | July 31, 2025 | MACKINNON, COLUM D | reporter.nih.gov |
| Blinded Comparison of Different Alpha-Synuclein Seeding Assays as Cutaneous Biomarkers of Lewy Body Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,335,086 | September 15, 2021 | August 31, 2025 | BEACH, THOMAS G | reporter.nih.gov |
| Investigations of Dementia in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,332,494 | September 23, 2021 | August 31, 2026 | PERLMUTTER, JOEL SYNES | reporter.nih.gov |
| Balance tele-rehabilitation with wearable technology for older adults with Parkinson disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,320,587 | September 20, 2022 | June 30, 2027 | KING, LAURIE | reporter.nih.gov |
| Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $2,315,618 | August 1, 2016 | June 30, 2027 | KOTZBAUER, PAUL T | reporter.nih.gov |
| LRRK2 Enzymatic Mechanisms of Neurodegeneration in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,313,250 | December 1, 2020 | November 30, 2025 | MOORE, DARREN JOHN | reporter.nih.gov |
| Leveraging a Natural Experiment to Determine the Effects of Integrated Palliative Care on Health Service Outcomes and Disparities in Parkinson Disease and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,307,536 | August 21, 2023 | July 31, 2026 | WILLIS, ALLISON | reporter.nih.gov |
| Determine the role of atmospheric particulate matter pollutants in contributing to Lewy Body Dementia | NIH | National Institute on Aging | 2023 | $2,296,059 | April 15, 2023 | March 31, 2026 | MAO, XIAOBO | reporter.nih.gov |
| Resilience, Dysregulation, and Rescue of Basal Ganglia Indirect Pathway Function in Progressive Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,285,634 | April 1, 2001 | April 30, 2027 | BEVAN, MARK D | reporter.nih.gov |
| Novel fibril-selective nanobody-based agents targeting intracellular and extracellular α-synuclein aggregates and prion-like propagation induced dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,280,379 | September 19, 2024 | August 31, 2027 | WANG, WENJING | reporter.nih.gov |
| Discovery and characterization of selective D4R antagonists and their evaluation in preclinical models of PD-LIDs | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,271,548 | July 1, 2021 | June 30, 2027 | HOPKINS, COREY R. | reporter.nih.gov |
| Propagation of Lewy pathology in Parkinson's and related disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,263,224 | March 13, 2015 | November 30, 2026 | LUK, KELVIN C | reporter.nih.gov |
| Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading | NIH | National Institute on Aging | 2021 to 2025 | $2,261,713 | September 30, 2021 | May 31, 2027 | MAO, XIAOBO | reporter.nih.gov |
| Biomarkers and Risk Factors for Prodromal Parkinson's Disease and its Progression | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,258,561 | April 1, 2022 | March 31, 2027 | ASCHERIO, ALBERTO | reporter.nih.gov |
| Molecular and Network Analyses of Lewy Body Dementia Pathogenesis | NIH | National Institute on Aging | 2021 | $2,252,599 | September 5, 2021 | August 31, 2024 | CHIN, LIH-SHEN | reporter.nih.gov |
| A Large-scale Extracellular Vesicle RNA-seq Resource for Parkinsons Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,250,030 | June 1, 2023 | May 31, 2025 | CRAIG, DAVID W | reporter.nih.gov |
| A Novel Instrument to Address Freezing of Gait in Parkinson's Patients | NIH | National Institute on Aging | 2024 to 2025 | $2,249,502 | September 15, 2021 | May 31, 2027 | CLARK, BRIAN R | reporter.nih.gov |
| Worldwide Tractometry Initiative to Investigate Brain Microstructure, Cognitive Impairment & Dementia in Parkinsons Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,243,095 | June 1, 2024 | May 31, 2027 | THOMPSON, PAUL M | reporter.nih.gov |
| Vulnerability of the ascending arousal network to alpha-synuclein pathology | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,234,905 | September 18, 2024 | August 31, 2027 | ALDRIDGE, GEORGINA | reporter.nih.gov |
| Axonal Transport of mRNA for Mitochondrial Proteins | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,224,546 | August 1, 2018 | April 30, 2025 | SCHWARZ, THOMAS L. | reporter.nih.gov |
| Peripheral Biomarkers for Early Diagnosis of Mixed Pathologies in AD/ADRD | NIH | National Institute on Aging | 2023 to 2025 | $2,219,859 | June 1, 2023 | February 29, 2028 | CHEN, SHU G. | reporter.nih.gov |
| Role of DJ1 in mitochondrial biogenergetics and neuronal metabolism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,212,107 | July 1, 2021 | June 30, 2026 | JONAS, ELIZABETH ANN | reporter.nih.gov |
| Identification and Verification of S-Nitrosylated Proteins in Bodily Fluids as Biomarkers for Parkinson's Disease and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,199,931 | July 1, 2021 | June 30, 2025 | NAKAMURA, TOMOHIRO | reporter.nih.gov |
| Neurostimulation of the Nucleus Basalis of Meynert for the cognitive-motor syndrome in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $2,192,915 | August 19, 2022 | July 31, 2024 | BRONTE-STEWART, HELEN | reporter.nih.gov |
| How Serine-129 Phosphorylation Status Affects the Spreading of α-Synuclein Pathology in Vivo: a Study in Knock-in Animals | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,192,716 | August 1, 2023 | July 31, 2026 | DETTMER, ULF | reporter.nih.gov |
| Molecular Segregation of Parkinson’s Disease by Patient-Derived Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,183,720 | June 1, 2020 | May 31, 2026 | FENG, JIAN | reporter.nih.gov |
| Mechanisms of gene regulation and RNA processing in synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,181,405 | July 1, 2020 | June 30, 2025 | MAZZULLI, JOSEPH R | reporter.nih.gov |
| Gene therapy targeting striatal dysfunction for Parkinson’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,153,443 | February 1, 2022 | January 31, 2027 | PAPA, STELLA M | reporter.nih.gov |
| DBS Protocols for Long-Lasting Therapeutic Benefit in Mouse and Primate Models of Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,148,826 | April 15, 2020 | February 28, 2026 | GITTIS, ARYN HILARY | reporter.nih.gov |
| Biomarkers of cognitive decline in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,148,559 | September 19, 2019 | June 30, 2024 | CHEN-PLOTKIN, ALICE S | reporter.nih.gov |
| Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,147,422 | August 15, 2019 | May 31, 2025 | KONG, QINGZHONG | reporter.nih.gov |
| α-Synuclein strain properties are associated with diagnosis of and progression to Parkinson's disease with dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,133,267 | March 1, 2022 | February 28, 2025 | MAO, XIAOBO | reporter.nih.gov |
| Polo-like-kinase-2-dependent α-Synuclein Serine-129 Phosphorylation: a Physiological RoleDuring Synaptic Activity | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,121,853 | July 15, 2022 | April 30, 2025 | DETTMER, ULF | reporter.nih.gov |
| The Gut Brain Parkinson's Disease Consortium (GBPDC): Coordinating and Data Management Center (CDMC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,119,283 | August 15, 2024 | June 30, 2029 | WRUCK, LISA M | reporter.nih.gov |
| Slow wave sleep as a biomarker of rehabilitation-induced cognitive improvement in Parkinson's disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,113,374 | April 1, 2021 | March 31, 2027 | AMARA, AMY WILLIS | reporter.nih.gov |
| Molecular Mechanism of the Parkinson's Disease-associated protein LRRK2 | NIH | National Institute on Aging | 2022 to 2025 | $2,105,974 | August 1, 2022 | May 31, 2027 | HOANG, QUYEN QUOC | reporter.nih.gov |
| Single-nucleus transcriptome profiling across multiple brain regions in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,099,553 | September 20, 2021 | August 31, 2023 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Comprehensive assessment of speech physiology and acoustics in Parkinson's disease progression | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2025 | $2,093,716 | February 2, 2023 | January 31, 2028 | STEPP, CARA E. | reporter.nih.gov |
| Mechanisms of Synaptic Dysfunction in Parkinson's and Other Synuclein-Linked Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $2,092,085 | June 1, 2022 | May 31, 2025 | MORGAN, JENNIFER REBECCA | reporter.nih.gov |
| Differentiation and characterization of conformational alpha-synuclein strains associated with Parkinson's disease and related synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,090,020 | August 15, 2021 | May 31, 2027 | SHAHNAWAZ, MOHAMMAD | reporter.nih.gov |
| Superoxide-sensitive radiotracer as a predictive biomarker of Parkinson's disease progression | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,077,197 | February 1, 2020 | December 31, 2025 | MCMANUS, MEAGAN JOY | reporter.nih.gov |
| Decoding the BETA-arrestin2-LMBRD2 cascade in ALPHA-synuclein pathogenesis. | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,069,215 | August 6, 2024 | July 31, 2027 | WOO, JUNGA "ALEXA" | reporter.nih.gov |
| Early Onset Parkinson’s disease subtypes and pathogenic mechanisms | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,066,422 | September 1, 2023 | July 31, 2028 | RIBOLDI, GIULIETTA MARIA | reporter.nih.gov |
| Peripheral Tissue Biomarker for Premorten Diagnosis of Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,065,446 | September 1, 2020 | June 30, 2025 | CHEN, SHU G. | reporter.nih.gov |
| Human iPSC-Based Personalized Cell Therapy of PD | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,062,628 | July 1, 2023 | April 30, 2028 | KIM, KWANG-SOO | reporter.nih.gov |
| VTA dopamine neurons and cognitive symptoms of Parkinson’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,043,714 | April 1, 2021 | March 31, 2027 | NARAYANAN, NANDAKUMAR | reporter.nih.gov |
| Corticosubthalamic Plasticity in the Parkinsonian State | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,040,666 | September 18, 2019 | June 30, 2025 | SMITH, YOLAND | reporter.nih.gov |
| Neuronal quality control and neuroprotection in tauopathies | NIH | National Institute on Aging | 2021 to 2024 | $2,040,301 | August 1, 2007 | April 30, 2026 | CHU, CHARLEEN T | reporter.nih.gov |
| Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,033,210 | June 1, 2020 | May 31, 2026 | HORAK, FAY BAHLING | reporter.nih.gov |
| In vivo synaptic and dopamine transporter imaging in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,029,333 | August 1, 2022 | January 31, 2027 | MATUSKEY, DAVID A | reporter.nih.gov |
| MicroRNAs in CNS-derived extracellular microvesicles as peripheral blood biomarkers for Alzheimer disease | NIH | National Institute on Aging | 2021 to 2023 | $2,025,805 | March 1, 2019 | June 30, 2025 | SHI, MIN | reporter.nih.gov |
| Pathways, mechanisms, and treatments of vocal communication deficits in a Parkinson rat model | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,018,747 | September 1, 2020 | June 30, 2030 | KELM-NELSON, CYNTHIA A | reporter.nih.gov |
| Circuit-Inspired Strategies to Restore Basal Ganglia Function in Mouse Models of Parkinson’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,015,497 | May 1, 2023 | April 30, 2031 | GITTIS, ARYN HILARY | reporter.nih.gov |
| Autophagon: an Autophagy-Functionalizing Gene Therapy Tool for Neurodegenerative Diseases | NIH | National Institute on Aging | 2023 to 2025 | $1,972,119 | March 15, 2022 | December 31, 2026 | YAKOUB, ABRAAM M. | reporter.nih.gov |
| Neuroinflammatory Biomarkers for Nigrostriatal Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,968,811 | June 1, 2019 | May 31, 2025 | PERLMUTTER, JOEL SYNES | reporter.nih.gov |
| Human Dopamine Grafts in Alpha-Synuclein Models of Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,967,447 | July 1, 2023 | June 30, 2028 | TABAR, VIVIANE | reporter.nih.gov |
| Prospective memory impairment in Parkinson disease-related cognitive decline: Intervention and mechanisms | NIH | National Institute on Aging | 2021 to 2024 | $1,964,673 | September 15, 2020 | May 31, 2026 | FOSTER, ERIN | reporter.nih.gov |
| Resolving the paradoxical effects of subthalamic deep-brain stimulation on inhibitory motor control | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,959,489 | July 1, 2020 | August 31, 2030 | WESSEL, JAN R | reporter.nih.gov |
| Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,957,052 | December 1, 2020 | November 30, 2026 | DAVIS, MARIE YNEZ | reporter.nih.gov |
| Determining the circuits and signals of sleep dysfunction in Parkinson's disease through chronic intracranial recordings and closed-loop Deep Brain Stimulation | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,956,339 | April 1, 2023 | February 29, 2028 | LITTLE, SIMON | reporter.nih.gov |
| The Pathophysiology of Network Synchrony in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,956,329 | September 30, 2016 | July 31, 2028 | POURATIAN, NADER | reporter.nih.gov |
| Optimizing Patient-Specific Deep Brain Stimulation Models Using Electrophysiology | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,955,899 | January 1, 2022 | December 31, 2026 | MIOCINOVIC, SVJETLANA | reporter.nih.gov |
| Mouse model studies of TMEM230-linked Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,954,066 | September 30, 2016 | November 30, 2026 | DENG, HAN-XIANG | reporter.nih.gov |
| Elucidating the role of NK cells in Lewy body diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,936,429 | February 1, 2021 | March 31, 2027 | LEE, JAE-KYUNG JAMISE | reporter.nih.gov |
| Development of selective amyloid-responsive fluorescent probes | NIH | National Institute on Aging | 2022 | $1,934,347 | June 1, 2022 | May 31, 2025 | YANG, JERRY | reporter.nih.gov |
| The impact of synaptic vesicle-binding of alpha-synuclein on neuron function and neuropathology | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,932,509 | June 1, 2020 | May 31, 2026 | BURRE, JACQUELINE | reporter.nih.gov |
| Molecular Genetic Analysis of TORC1 and TORC2 Signaling in Neuronal Maintenance | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,926,179 | December 15, 2013 | November 30, 2029 | LU, BINGWEI | reporter.nih.gov |
| Striatal Mechanisms of Dyskinesia and Impulse Control in Parkinson’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,915,009 | July 1, 2018 | April 30, 2028 | NELSON, ALEXANDRA | reporter.nih.gov |
| Voltage Imaging Analysis of Striatal Network Dynamics Related to Movement, Parkinson's Disease and Deep Brain Stimulation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,912,300 | April 1, 2020 | March 31, 2026 | HAN, XUE | reporter.nih.gov |
| Role of GlcSph in cognitive deficits in Lewy body dementias | NIH | National Institute on Aging | 2023 to 2025 | $1,911,743 | May 15, 2023 | March 31, 2028 | VOLPICELLI-DALEY, LAURA A. | reporter.nih.gov |
| ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration | NIH | National Institute on Aging | 2021 to 2023 | $1,900,986 | February 1, 2019 | November 30, 2024 | LINDBERG, IRIS | reporter.nih.gov |
| Mechanisms and indicators of inflammasome signaling in Parkinson’s disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,896,582 | September 21, 2021 | August 31, 2025 | HAVRDA, MATTHEW CHARLES | reporter.nih.gov |
| Exploiting New Fibril Structures to Understand the Biophysical Basis for Oligomerization and Toxicity of Alpha-Synuclein | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,895,793 | September 30, 2020 | August 31, 2025 | SACHS, JONATHAN N | reporter.nih.gov |
| The role of VAMP2 in alpha-synuclein function and pathology | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,885,097 | April 15, 2021 | March 31, 2027 | DIAO, JIAJIE | reporter.nih.gov |
| Towards Generating a Multimodal and Multivariate Classification Model from Imaging and Non-Imaging Measures for Accurate Diagnosis and Monitoring of Dementia in Parkinsons disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,881,677 | September 1, 2020 | June 30, 2026 | MISHRA, VIRENDRA R | reporter.nih.gov |
| A theranostic system for ultrasound-facilitated blood-brain barrier opening | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $1,879,799 | March 1, 2020 | December 31, 2023 | KONOFAGOU, ELISA E. | reporter.nih.gov |
| Linear predictive coding of EEG Activity for Diagnosis of Parkinson's Disease (LEAD-PD) | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,876,731 | June 1, 2023 | May 31, 2026 | UC, ERGUN Y | reporter.nih.gov |
| Neuronal roles of Parkinsons Disease Vps13C in regulating autophagy and calcium dynamics | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,856,046 | September 30, 2020 | January 31, 2026 | CARAVEOPISO, GABRIELA | reporter.nih.gov |
| Understanding Cell-type Vulnerability and Oxidative Stress Pathology in Parkinson's Disease Using Isogenic Human Dopaminergic Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,850,776 | September 1, 2020 | August 31, 2025 | BLANCHARD, JOEL WILLIAM | reporter.nih.gov |
| Identifying Circuit Dynamics Underlying Motor Dysfunction in Parkinsons Disease Using Real-Time Neural Control | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,831,432 | July 1, 2023 | June 30, 2028 | ESCOBAR SANABRIA, DAVID | reporter.nih.gov |
| Studying Aggregation in Neurodegenerative Disease using Synthetic Proteins | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,825,919 | February 15, 2019 | July 31, 2026 | PETERSSON, ERNEST JAMES | reporter.nih.gov |
| Chloride Homeostasis in Lysosomal Function and Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,813,734 | July 1, 2022 | April 30, 2028 | MAO, ZIXU | reporter.nih.gov |
| Proteostasis dysregulation and alpha-synuclein | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,813,410 | May 1, 2020 | April 30, 2025 | QI, XIN | reporter.nih.gov |
| Novel roles of VGLUT in sex differences in dopamine neuron vulnerability to environmental toxicant-induced neurodegeneration | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,811,672 | March 6, 2023 | December 31, 2027 | FREYBERG, ZACHARY | reporter.nih.gov |
| Chemogenetic Inactivation of the Primate Internal Globus Pallidus as a Treatment for Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,806,350 | September 27, 2022 | August 31, 2027 | GALVAN, ADRIANA | reporter.nih.gov |
| Sleep-specific DBS therapy in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,806,248 | April 1, 2023 | March 31, 2028 | JOHNSON, LUKE AARON | reporter.nih.gov |
| Regulation of PINK1 and PARKIN-Dependent Mitophagy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,796,738 | September 25, 2013 | April 30, 2026 | HARPER, JEFFREY W | reporter.nih.gov |
| The contribution of the vermiform appendix to Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,785,152 | July 1, 2020 | June 30, 2025 | BRUNDIN, LENA CECILIA | reporter.nih.gov |
| BIOMARKER DISCOVERY AND VALIDATION IN PSP | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,775,155 | August 1, 2018 | April 30, 2025 | PANTELYAT, ALEXANDER Y. | reporter.nih.gov |
| Precision-Mapping Functional Connectivity in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,773,631 | February 1, 2023 | December 31, 2027 | CAMPBELL, MEGHAN C | reporter.nih.gov |
| Epigenetic contributions to symptom asymmetry in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,772,605 | April 1, 2020 | March 31, 2025 | COETZEE, GERHARD A | reporter.nih.gov |
| Exploring mechanisms of Parkinson's disease-linked D620N VPS35 in rat models | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,772,605 | July 1, 2020 | June 30, 2025 | MOORE, DARREN JOHN | reporter.nih.gov |
| Neuromechanical modeling of postural responses: Cortical mechanisms of balance impairments in Parkinson's disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,771,273 | April 1, 2004 | August 31, 2029 | TING, LENA H | reporter.nih.gov |
| Neurovascular Effects of Dopamine Replacement Therapy in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,769,883 | September 16, 2019 | May 31, 2025 | EIDELBERG, DAVID | reporter.nih.gov |
| Role of APOE in endosomal processing of alpha-synuclein | NIH | National Institute on Aging | 2023 to 2024 | $1,757,895 | September 1, 2023 | August 31, 2025 | DAVIS, ALBERT A | reporter.nih.gov |
| Parkinson Disease Neural Circuitry and Gastrointestinal Pathobiology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,756,788 | August 1, 2023 | May 31, 2027 | CAMILLERI, MICHAEL L. | reporter.nih.gov |
| CYClical Lower Extremity exercise for Parkinsons trial (CYCLE Trial) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,752,215 | September 1, 2011 | April 30, 2026 | ALBERTS, JAY L. | reporter.nih.gov |
| Cortical Network Modulation by Subthalamic Nucleus Deep Brain Stimulation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,739,970 | September 6, 2019 | June 30, 2025 | HERSHEY, TAMARA G | reporter.nih.gov |
| Compensatory Mitochondrial Protective Mechanisms Against Oxidative Stress in PD | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,730,971 | April 15, 2022 | March 31, 2027 | KANTHASAMY, ANUMANTHA GOUNDER | reporter.nih.gov |
| Fluorescent IRE sensor for synucleinopathy drug discovery | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $1,728,231 | September 22, 2022 | August 31, 2025 | SHEN, WEN | reporter.nih.gov |
| Genetic and Molecular Basis of Longevity | NIH | National Institute on Aging | 2022 to 2025 | $1,719,200 | April 1, 1999 | May 31, 2027 | RUVKUN, GARY B | reporter.nih.gov |
| Synergistic Enhancement of ER proteostasis, trafficking, and lysosomes as treatments for Dementia with Lewy bodies and Parkinson’s disease-dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,707,089 | August 15, 2024 | July 31, 2027 | MAZZULLI, JOSEPH R | reporter.nih.gov |
| Combinatorial effects of PTMs on a-Synuclein structure, function and aggregation | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $1,706,062 | April 15, 2022 | March 31, 2025 | RHOADES, ELIZABETH | reporter.nih.gov |
| Molecular Mechanisms of Oxidation Resistance 1 in Parkinson's disease and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,704,192 | August 1, 2023 | May 31, 2028 | THOMAS, BOBBY | reporter.nih.gov |
| Role of N-terminal acetylation in alpha synuclein stability, function, and therapeutic targeting in synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,693,159 | September 13, 2024 | July 31, 2029 | RHOADES, ELIZABETH | reporter.nih.gov |
| Tissue Engineered Nigrostriatal Pathway for Anatomical Tract Reconstruction in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,690,151 | September 1, 2023 | July 31, 2028 | CULLEN, DANIEL KACY | reporter.nih.gov |
| Cortical Alpha-Synuclein in Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,683,467 | February 15, 2023 | January 31, 2028 | ALDRIDGE, GEORGINA | reporter.nih.gov |
| Cortical correlates of gait in Parkinson's disease: impact of medication and cueing | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,677,923 | February 23, 2023 | January 31, 2028 | MANCINI, MARTINA | reporter.nih.gov |
| Reciprocal interactions between cortical circuit dysfunction and α-synuclein pathology | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,674,295 | February 1, 2023 | January 31, 2028 | ZEIGER, WILLIAM ABEL | reporter.nih.gov |
| Advancing personalized medicine in PD using harmonized multi-site clinical data | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,666,423 | September 30, 2020 | August 31, 2025 | ERTEFAIE, ASHKAN | reporter.nih.gov |
| Cholinergic Mechanisms in Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,653,870 | April 1, 2023 | March 31, 2028 | MOEHLE, MARK S | reporter.nih.gov |
| Alpha-Synuclein aberrantly modifies the nanoscale distribution and function of ion channels to promote neuronal cytotoxicity | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,650,534 | April 1, 2023 | March 31, 2028 | DICKSON, EAMONN JAMES | reporter.nih.gov |
| A Dose Selection Trial of Light Therapy for Impaired Sleep in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,648,972 | September 15, 2019 | June 30, 2024 | VIDENOVIC, ALEKSANDAR | reporter.nih.gov |
| Parkinson Disease Clinical Subtypes: Validation, Clinical Utility, and Biological Correlates | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,648,353 | April 1, 2017 | April 30, 2028 | CAMPBELL, MEGHAN C | reporter.nih.gov |
| Clinical performance testing of neuropacs in Parkinsonism diagnosis | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,647,650 | June 15, 2023 | August 31, 2026 | BARMPOUTIS, ANGELOS | reporter.nih.gov |
| Biophysical determination of the underlying cause of α-Syn oligomer toxicity | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,625,052 | August 15, 2021 | July 31, 2027 | KUROUSKI, DMITRY | reporter.nih.gov |
| Mechanisms of Low-Dose Ketamine Treatment for Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,624,779 | July 1, 2021 | June 30, 2025 | FALK, TORSTEN | reporter.nih.gov |
| The cross-talk between a-Synucleinopathies and T cell immunity in ADRD | NIH | National Institute on Aging | 2024 to 2025 | $1,621,812 | August 15, 2024 | April 30, 2030 | MAO, XIAOBO | reporter.nih.gov |
| MIF Nuclease actions in Synuclein Dementias | NIH | National Institute on Aging | 2024 to 2025 | $1,620,473 | December 1, 2023 | November 30, 2028 | DAWSON, VALINA L. | reporter.nih.gov |
| Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,619,186 | May 1, 2021 | April 30, 2023 | MACLEOD, KAREN | reporter.nih.gov |
| STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,611,362 | September 30, 2018 | August 31, 2023 | KOTZBAUER, PAUL T | reporter.nih.gov |
| Dendrite regulation by the mitochondrial kinase PINK1: Implications for PD/LBD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,596,950 | September 1, 2017 | June 30, 2029 | CHU, CHARLEEN T | reporter.nih.gov |
| Genetic Silencing of Striatal CaV1.3 Calcium Channels as a Potent Antidyskinetic Therapy for PD | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,596,160 | September 30, 2018 | May 31, 2029 | STEECE-COLLIER, KATHY | reporter.nih.gov |
| Multi-scale functional connectivity in preclinical models of Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,585,539 | January 1, 2022 | November 30, 2026 | STOKES, ASHLEY M | reporter.nih.gov |
| CSF Oligomeric α-synuclein targeted nano scavengers as a Parkinson's disease theranostic | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,585,446 | September 18, 2024 | June 30, 2029 | TANIFUM, ERIC | reporter.nih.gov |
| Brain and Behavioral Indicators of Risk for Parkinsonism among Adolescents with Early Pesticide Exposure | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,583,679 | January 15, 2019 | December 31, 2024 | RAUH, VIRGINIA A | reporter.nih.gov |
| Autoimmune features of neurodegenerative disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,580,796 | September 30, 2018 | July 31, 2024 | SULZER, DAVID | reporter.nih.gov |
| Investigations of Dementia in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,574,996 | May 1, 2011 | August 31, 2023 | PERLMUTTER, JOEL SYNES | reporter.nih.gov |
| Changes across the lifespan in the use of heuristics to guide decision-making | NIH | National Institute on Aging | 2022 to 2023 | $1,573,961 | May 1, 2019 | February 28, 2026 | BASSO, MICHELE A | reporter.nih.gov |
| Role of arginylation in prevention of alpha synuclein-driven neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,573,670 | April 15, 2019 | March 31, 2025 | KASHINA, ANNA S | reporter.nih.gov |
| Effect of Agent and Host Factors on Alpha-Synuclein Strain Pathogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,572,020 | January 15, 2022 | July 31, 2027 | WOERMAN, AMANDA L. | reporter.nih.gov |
| Metabolic Vulnerability of Synapses in Neurodegenerative Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,571,619 | February 1, 2020 | January 31, 2026 | RYAN, TIMOTHY AIDAN | reporter.nih.gov |
| Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration | NIH | National Institute of Environmental Health Sciences | 2022 to 2023 | $1,566,923 | March 4, 2022 | July 31, 2023 | RICHARDSON, JASON R | reporter.nih.gov |
| Molecular Assessment of Cause and Consequence of Cellular Senescence in Diverse Midbrain Cell Types in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,562,350 | July 15, 2022 | June 30, 2027 | RIESSLAND, MARKUS | reporter.nih.gov |
| Genome-wide Prediction of Dementia in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,554,981 | September 20, 2019 | December 31, 2023 | SCHERZER, CLEMENS R | reporter.nih.gov |
| Mechanisms of pesticide-induced neuroinflammation and parkinsonism in aging mice. | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $1,553,785 | February 9, 2022 | May 14, 2025 | HAVRDA, MATTHEW CHARLES | reporter.nih.gov |
| Daily Experiences and Well-being among Caregivers for Older Adults Experiencing Lewy Body Dementia. | NIH | National Institute on Aging | 2024 to 2025 | $1,553,585 | May 1, 2024 | February 28, 2029 | FINGERMAN, KAREN L | reporter.nih.gov |
| Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,552,312 | July 1, 2018 | April 30, 2024 | SCHWARZSCHILD, MICHAEL A | reporter.nih.gov |
| The Role of KCa3.1 in Microglial function and in Parkinsons disease pathogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,547,582 | July 15, 2021 | April 30, 2027 | KANTHASAMY, ARTHI | reporter.nih.gov |
| Investigating the Neurobiology of Early Cognitive Impairment | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,547,395 | February 1, 2024 | January 31, 2029 | HUNTLEY, GEORGE W. | reporter.nih.gov |
| Elucidating the Pathomechanisms of APOE4 in Lewy Body Dementia | NIH | National Institute on Aging | 2024 to 2025 | $1,538,709 | July 1, 2024 | March 31, 2029 | ZHAO, NA | reporter.nih.gov |
| Lewy Body Dementia Biomarkers | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,536,368 | September 25, 2016 | November 30, 2023 | FREY, KIRK A. | reporter.nih.gov |
| Direct CNS Delivery System for BDNF AntagoNATs using Heterotopic Mucosal Grafting for the Treatment of Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,535,794 | January 1, 2019 | August 31, 2024 | BLEIER, BENJAMIN | reporter.nih.gov |
| NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESE NEUROTOXICITY | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,525,888 | September 12, 2019 | May 31, 2024 | CRISWELL, SUSAN | reporter.nih.gov |
| Sing for Your Saunter: Using Self-Generated Rhythmic Cues to Enhance Gait in Parkinson's | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $1,517,088 | September 15, 2019 | June 30, 2026 | EARHART, GAMMON M. | reporter.nih.gov |
| Mechanisms of spreading proteinopathy in Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,512,234 | September 15, 2021 | August 31, 2024 | UNNI, VIVEK | reporter.nih.gov |
| The Function of Synuclein | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,510,563 | February 1, 2019 | January 31, 2024 | EDWARDS, ROBERT H | reporter.nih.gov |
| Glial Involvement in REDOX Homeostasis in the Substantia Nigra | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,509,712 | July 1, 2021 | April 30, 2027 | COWELL, RITA MARIE | reporter.nih.gov |
| Mapping Synaptic Density in Prodromal and Manifest Lewy Body Dementia | NIH | National Institute on Aging | 2024 to 2025 | $1,505,046 | September 25, 2024 | July 31, 2030 | GALLAGHER, CATHERINE L. | reporter.nih.gov |
| Mitochondrial Sirtuin 3 in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,499,835 | June 1, 2019 | May 31, 2025 | MCLEAN, PAMELA J | reporter.nih.gov |
| Enhancing Physical Therapy with Brain Stimulation for Treating Postural Instability | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,499,766 | September 1, 2021 | August 31, 2024 | WAGNER, TIMOTHY ANDREW | reporter.nih.gov |
| Quantitative MR Imaging of Vascular Factors in Parkinsons Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,494,509 | September 30, 2020 | June 30, 2026 | HERNANDEZ-GARCIA, LUIS | reporter.nih.gov |
| Genome-Wide Prediction of Dementia in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,487,365 | September 20, 2019 | December 31, 2026 | SCHERZER, CLEMENS R | reporter.nih.gov |
| Understanding biomarkers of cognitive decline in Lewy body diseases | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,481,568 | September 19, 2019 | June 30, 2026 | CHEN-PLOTKIN, ALICE S | reporter.nih.gov |
| NINDS CENTER FOR CLINICAL RESEARCH | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,478,090 | September 30, 2017 | September 29, 2022 | CLEMONS, TRACI E | reporter.nih.gov |
| Anti-inflammatory signals and neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,467,006 | September 1, 2024 | June 30, 2028 | CONTI, BRUNO | reporter.nih.gov |
| SCH: Enabling Data Outsourcing and Sharing for AI-powered Parkinson's Research | NIH | National Library of Medicine | 2021 to 2024 | $1,453,331 | September 3, 2021 | May 31, 2026 | CHEN, SHIGANG | reporter.nih.gov |
| LEGENNDS: Linking Epidemiology and GEnetics of Neurodevelopmental and Neurodegenerative Disorders Study | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $1,448,091 | May 1, 2023 | April 30, 2028 | LEE, BRIAN KANE | reporter.nih.gov |
| Molecular and Network Analyses of Lewy Body Dementia Pathogenesis | NIH | National Institute on Aging | 2024 to 2025 | $1,448,065 | September 5, 2021 | August 31, 2027 | CHIN, LIH-SHEN | reporter.nih.gov |
| A cross-sectional and longitudinal study of gut microbiota in Parkinson's disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,444,898 | August 15, 2024 | June 30, 2029 | XIE, TAO | reporter.nih.gov |
| The Bidirectional Gut-Microbiota-Brain Axis in Parkinson’s disease: integrating mechanistic biomarkers of disease severity and progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,441,314 | August 15, 2024 | June 30, 2029 | KESHAVARZIAN, ALI | reporter.nih.gov |
| Effects of deep brain stimulation (DBS) on laryngeal function and associated behaviors in Parkinson Disease | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2025 | $1,439,077 | August 10, 2023 | July 31, 2028 | HEGLAND, KAREN W | reporter.nih.gov |
| Role of Rab27b in synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,433,631 | September 1, 2021 | August 31, 2024 | YACOUBIAN, TALENE ALENE | reporter.nih.gov |
| A causal framework of communicative participation in people with Parkinson's disease. | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2025 | $1,432,497 | June 15, 2023 | May 31, 2028 | BORRIE, STEPHANIE ANNA | reporter.nih.gov |
| S-Nitrosylation-Dependent Pathological Spread of Abnormal Proteins in Frontotemporal Dementia and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,431,052 | August 1, 2021 | July 31, 2027 | NAKAMURA, TOMOHIRO | reporter.nih.gov |
| Calcium homeostasis in organelles | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,430,661 | July 1, 2020 | May 31, 2025 | KRISHNAN, YAMUNA | reporter.nih.gov |
| Dopaminergic and Muscarinic Signaling in the Striatum | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,430,223 | July 1, 2024 | June 30, 2027 | SURMEIER, DALTON JAMES | reporter.nih.gov |
| Motor cortical circuitry adaptations in experimental Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,430,012 | April 15, 2021 | March 31, 2024 | CHU, HONG-YUAN | reporter.nih.gov |
| 14-3-3 phosphorylation in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,428,181 | September 15, 2019 | May 31, 2025 | YACOUBIAN, TALENE ALENE | reporter.nih.gov |
| Mayo Clinic Consortium for Gut Brain Communication in Parkinson (Administrative Supplement) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,425,498 | September 1, 2024 | June 30, 2029 | BHARUCHA, ADIL E. | reporter.nih.gov |
| Molecular Regulation of LRRK2 in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,424,238 | December 1, 2019 | November 30, 2025 | XIONG, YULAN | reporter.nih.gov |
| Simplified, Scalable 24-hour adaptive deep brain stimulation for Parkinson’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,419,954 | January 15, 2025 | December 31, 2025 | STARR, PHILIP ANDREW | reporter.nih.gov |
| Mechanistic Dissection of Lipase (LIPE) Regulation of Fatty Acid Homeostasis as a Parkinson's Disease and Lewy Body Dementia Therapeutic Strategy | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,408,421 | June 1, 2024 | May 31, 2029 | FANNING, SARANNA | reporter.nih.gov |
| Consultative Physical Therapy: A Physical Activity and Exercise Implementation Strategy in Parkinson's | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,404,802 | June 13, 2023 | May 31, 2028 | RAFFERTY, MIRIAM ROSE | reporter.nih.gov |
| NADPH Oxidase 2 in Parkinson's Disease Pathogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,403,816 | December 5, 2022 | November 30, 2027 | DI MAIO, ROBERTO | reporter.nih.gov |
| Identification of mechanisms by which cytisine and estrogen inhibit ER stress and exert neuroprotection in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,398,086 | February 15, 2020 | January 31, 2026 | SRINIVASAN, RAHUL | reporter.nih.gov |
| Interaction of Pyrethroid Exposure and the Microbiome on Parkinson's Disease related Pathologies | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $1,391,256 | February 9, 2022 | November 30, 2026 | SAMPSON, TIMOTHY ROBERT | reporter.nih.gov |
| Towards a comprehensive understanding of the neurotoxic spread of α-synuclein from gut to brain in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,386,000 | September 17, 2024 | August 31, 2027 | MOR, DANIELLE EMILLE | reporter.nih.gov |
| Stimulus-evoked directional field potentials to guide subthalamic and pallidal DBS for PD | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,382,351 | December 18, 2023 | November 30, 2028 | WALKER, HARRISON CARROLL | reporter.nih.gov |
| An Application of Advanced Imaging and Visualization to Clinical Deep Brain Stimulation | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,380,785 | January 1, 2021 | January 31, 2026 | MCINTYRE, CAMERON | reporter.nih.gov |
| TMEM230 and Neurodegeneration in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,376,101 | September 30, 2020 | August 31, 2025 | XIA, XUGANG | reporter.nih.gov |
| The Role of Aberrant Histone Acetylation in the Pathogenesis of Parkinson’s Disease and Related Synucleinopathies. | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,366,666 | July 17, 2024 | June 30, 2028 | SOLDNER, FRANK | reporter.nih.gov |
| Defining mechanisms of AAA+ disaggregases | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,366,630 | January 1, 2013 | May 31, 2025 | SHORTER, JAMES | reporter.nih.gov |
| Effects of 14-3-3θ phosphorylation vesicular transport and alpha-synuclein aggregation | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,361,977 | June 1, 2025 | May 31, 2027 | YACOUBIAN, TALENE ALENE | reporter.nih.gov |
| Biophysical Characterization of Subthalamic Local Field Potentials in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,360,496 | February 1, 2021 | January 31, 2025 | MCINTYRE, CAMERON | reporter.nih.gov |
| Structural analysis of the human LRRK2 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,351,350 | May 17, 2023 | April 30, 2028 | LEE, CHIA-HSUEH | reporter.nih.gov |
| Noninvasive Biomarkers to Advance Emerging DBS Electrode Technologies in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,349,258 | September 30, 2016 | June 30, 2023 | WALKER, HARRISON CARROLL | reporter.nih.gov |
| The Pallidohabenular System in Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,344,615 | January 4, 2024 | December 31, 2028 | SMITH, YOLAND | reporter.nih.gov |
| Biologically Novel Mouse Models of PD with Progressive Synucleinopathy and Early-Onset Tremor and Motor Deficits Responsive to L-DOPA | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,344,552 | May 15, 2019 | June 30, 2027 | NUBER, SILKE | reporter.nih.gov |
| Role of altered gut immune response in Lewy Body Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,338,898 | September 1, 2024 | June 30, 2029 | POSTON, KATHLEEN LOMBARD | reporter.nih.gov |
| Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,331,032 | May 1, 2023 | April 30, 2027 | KIM, KWANG-SOO | reporter.nih.gov |
| Striatal Trans-Synaptic Signaling Mechanism in Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,328,422 | September 1, 2024 | August 31, 2029 | DRAVID, SHASHANK MANOHAR | reporter.nih.gov |
| Glial Involvement in REDOX Homeostasis in the Substantia Nigra | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,326,101 | July 1, 2021 | November 30, 2022 | COWELL, RITA MARIE | reporter.nih.gov |
| ATP13A2 and Susceptibility to Neurodegeneration | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $1,324,559 | September 28, 2020 | June 30, 2025 | FLEMING, SHEILA | reporter.nih.gov |
| The Role of GPNMB in Parkinson's Disease. | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,312,338 | August 1, 2024 | June 30, 2029 | SOLDNER, FRANK | reporter.nih.gov |
| Phase I Cell Therapy for Maintaining Cholinergic Circuits in the Spectrum of Alzheimer’s Disease | NIH | National Institute on Aging | 2024 to 2025 | $1,310,770 | June 15, 2024 | May 31, 2029 | GERHARDT, GREG A. | reporter.nih.gov |
| Identifying Targets for Fall-prevention Rehabilitation in People with Parkinson’s Disease | NIH | National Institute on Aging | 2024 to 2025 | $1,293,402 | September 1, 2024 | June 30, 2029 | PETERSON, DANIEL SOREN | reporter.nih.gov |
| Intrinsically disordered domains of α-synuclein: effect of fibril formation and fibril polymorphs | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,287,494 | April 1, 2024 | March 31, 2029 | SIEMER, ANSGAR B | reporter.nih.gov |
| Regulation of Motor Function in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,286,670 | March 1, 2004 | May 31, 2025 | PAPA, STELLA M | reporter.nih.gov |
| Analysis of Cutaneous Phosphorylated alpha-Synuclein to Identify Patients at Risk of Progressing from Essential Tremor to Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,276,662 | September 5, 2025 | August 31, 2028 | GIBBONS, CHRISTOPHER H | reporter.nih.gov |
| Synaptic Dysfunction and Energy Failure in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,274,048 | June 15, 2022 | March 31, 2027 | ZHANG, HUI | reporter.nih.gov |
| Systematic investigation of disease-associated, regulatory variation; illuminating their prediction, molecular consequences and mechanisms contributing to risk of Parkinson disease (PD) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,260,922 | July 22, 2024 | June 30, 2029 | MCCALLION, ANDREW S | reporter.nih.gov |
| Targeting the FBXW7/PGC1 Pathway as a Therapeutic Strategy for Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,256,193 | March 15, 2024 | February 28, 2029 | SIMON, DAVID K. | reporter.nih.gov |
| Deciphering Neuronal Control of Behavioral Initiation and Suppression | NIH | Office of the Director, National Institutes of Health | 2023 to 2025 | $1,252,500 | September 22, 2023 | July 31, 2028 | FERENCZI, EMILY ANNE | reporter.nih.gov |
| Dieldrin-induced differential gene methylation and parkinsonian toxicity (R01ES031237) | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,247,552 | November 10, 2022 | October 31, 2026 | BERNSTEIN, ALISON | reporter.nih.gov |
| Striatal Neuroplasticity Mechanisms that Preserve Motor Behavior in a model of Parkinsonâs Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,246,445 | April 1, 2013 | July 31, 2024 | SEAL, REBECCA P | reporter.nih.gov |
| Retinal Determinants of Circadian Function and Sleep-Wake Cycles in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $1,244,735 | September 1, 2023 | May 31, 2029 | VIDENOVIC, ALEKSANDAR | reporter.nih.gov |
| Role of pathogenic Parkinsonian mutations in the seeding and propagation of alpha-synuclein in the CNS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,239,324 | April 1, 2019 | March 31, 2024 | SMEYNE, RICHARD J | reporter.nih.gov |
| Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,235,033 | September 1, 2018 | August 31, 2025 | HUANG, CHIFU | reporter.nih.gov |
| Stimulus-evoked directional field potentials to guide subthalamic and pallidal DBS for PD | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,232,410 | December 18, 2023 | November 30, 2024 | WALKER, HARRISON CARROLL | reporter.nih.gov |
| Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,232,074 | February 14, 2024 | December 31, 2026 | RICHARDSON, JASON R | reporter.nih.gov |
| Understanding the Mechanism of Pathological alpha-Synuclein Transmission | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,228,125 | September 17, 2019 | June 30, 2024 | MAO, XIAOBO | reporter.nih.gov |
| Which mechanisms of pollutant-induced mitochondrial dysfunction cause dopaminergic neurodegeneration? | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,226,895 | January 1, 2023 | October 31, 2025 | MEYER, JOEL NEWMAN | reporter.nih.gov |
| Controlling Bacterial Amyloid Formation and the Influence of Curli Subunits on Pathogenic Alpha-synuclein Aggregation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,226,404 | April 1, 2016 | March 31, 2029 | CHAPMAN, MATTHEW RICHARD | reporter.nih.gov |
| The role of Lamp1 and lipid transport in the regulation of vesicle identity | NIH | National Institute on Aging | 2024 to 2025 | $1,216,748 | February 1, 2024 | January 31, 2029 | JENNY, ANDREAS | reporter.nih.gov |
| Dementia with Lewy Bodies Consortium | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,215,498 | September 1, 2025 | August 31, 2028 | LEVERENZ, JAMES BRUCE | reporter.nih.gov |
| A Consortium for Gut-Brain Communication in Parkinson's Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,215,100 | September 1, 2024 | June 30, 2029 | KUO, BRADEN | reporter.nih.gov |
| 2023 NINDS Landis Mentoring Award | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,212,183 | September 30, 2014 | March 31, 2024 | STARR, PHILIP ANDREW | reporter.nih.gov |
| The Interplay between Genetics and Aerobic Exercise to Slow Parkinson's disease (GEARS) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,210,130 | January 18, 2024 | December 31, 2028 | ALBERTS, JAY L. | reporter.nih.gov |
| PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for SmallBusiness Innovation Research Grant Applications (Parent SBIR [R43/R44] ClinicalTrial Not Allowed | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,198,087 | September 30, 2020 | August 31, 2023 | LEVINE, TODD | reporter.nih.gov |
| Neurophysiological Biomarkers of Movement Facilitation in Parkinson’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,184,732 | September 1, 2021 | August 31, 2026 | CROSS, KATHRYN AMY | reporter.nih.gov |
| Identifying and targeting the neural basis of depression in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,184,648 | April 1, 2024 | March 31, 2029 | HOLMES, SOPHIE | reporter.nih.gov |
| SCH: An Augmented Reality Neurorehabilitation System for Monitoring and Management of Motor Symptoms of Parkinson's Disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,183,447 | August 1, 2022 | July 31, 2027 | FUCHS, HENRY | reporter.nih.gov |
| Reducing falls with Varenicline in Hypocholinergic Parkinson disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,180,332 | September 19, 2024 | August 31, 2025 | KOTAGAL, VIKAS | reporter.nih.gov |
| Investigate neuroinflammation in the brain of PD using S1P1 radioligands | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,174,036 | February 20, 2024 | January 31, 2029 | TU, ZHUDE | reporter.nih.gov |
| High-throughput neurovascular-unit-on-a-chip with OASIS for modeling Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,171,566 | April 1, 2024 | March 31, 2029 | KIM, DEOK-HO | reporter.nih.gov |
| Characterizing the pathophysiological role of the pallido-thalamocortical motor pathway in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,169,275 | January 1, 2024 | December 31, 2028 | AMAN, JOSHUA E | reporter.nih.gov |
| Urate-LRRK2 interactions in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,165,465 | August 1, 2019 | May 31, 2025 | SCHWARZSCHILD, MICHAEL A | reporter.nih.gov |
| Frontal midline delta/theta rhythms and cognitive control in PD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,156,742 | September 25, 2017 | December 31, 2029 | NARAYANAN, NANDAKUMAR | reporter.nih.gov |
| Studies of SLC41A1, a Mg2+-Transporting Protein Linked to Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,142,880 | August 1, 2023 | May 31, 2028 | ZUBCEVIC, LEJLA | reporter.nih.gov |
| Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,141,509 | May 15, 2019 | March 31, 2024 | NUBER, SILKE | reporter.nih.gov |
| Walking and mHealth to Increase Participation in Parkinson Disease (WHIP-PD) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,138,081 | June 15, 2018 | April 30, 2024 | ELLIS, THERESA | reporter.nih.gov |
| Functional Magnetic Resonance Imaging and Deep Learning to Improve Deep Brain Stimulation Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,135,169 | September 19, 2023 | November 30, 2028 | AJALA, AFIS | reporter.nih.gov |
| DBS-Expert Pro: Automated Deep Brain Stimulation Programming Using Functional Mapping | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,134,607 | August 21, 2025 | June 30, 2027 | HELDMAN, DUSTIN A. | reporter.nih.gov |
| Prevention of complement and immune-mediated Lewy body dementia | NIH | National Institute on Aging | 2021 to 2022 | $1,133,146 | August 15, 2018 | April 30, 2023 | ISACSON, OLE | reporter.nih.gov |
| Closed Loop Deep Brain Stimulation for Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,131,593 | July 1, 2022 | June 30, 2023 | STARR, PHILIP ANDREW | reporter.nih.gov |
| Listener training for improved intelligibility of people with Parkinson's disease | NIH | National Institute on Deafness and Other Communication Disorders | 2024 to 2025 | $1,128,236 | September 1, 2024 | May 31, 2029 | BORRIE, STEPHANIE ANNA | reporter.nih.gov |
| Intersection of GBA and LRRK2 in Lewy Body Dementia | NIH | National Institute on Aging | 2024 to 2025 | $1,127,274 | July 15, 2024 | April 30, 2029 | LAVOIE, MATTHEW J | reporter.nih.gov |
| Molecular mechanisms of alpha-synuclein induction and spread of pathobiology | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,123,395 | March 1, 2023 | February 28, 2026 | GIASSON, BENOIT I | reporter.nih.gov |
| Mechanisms of Synaptic Dysfunction in Parkinson s and Other Synuclein-Linked Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,117,086 | January 15, 2012 | May 31, 2027 | MORGAN, JENNIFER REBECCA | reporter.nih.gov |
| Innovative systemic gene therapy for treating Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,110,485 | May 15, 2019 | August 28, 2023 | SUK, JUNG SOO | reporter.nih.gov |
| Development of S-PCT3010 to treat cognitive impairment in Alzheimers Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,108,765 | March 1, 2021 | February 28, 2022 | SIELECKI, THAIS | reporter.nih.gov |
| Benefits of Exercise on Nigrostriatal Dopamine and Motor Behavior | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,107,146 | January 1, 2024 | December 31, 2028 | RICE, MARGARET E | reporter.nih.gov |
| Impaired sensory filtering as a mechanism of Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,102,613 | August 1, 2022 | July 31, 2025 | IRWIN, ZACHARY THOMAS | reporter.nih.gov |
| Tau-dependent cognitive deficits in alpha-synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,101,680 | May 15, 2018 | February 28, 2025 | LEE, MICHAEL K | reporter.nih.gov |
| Clinical trial readiness in X-linked dystonia parkinsonism: assessment of sensor-based and blood biomarkers for early detection and monitoring disease progression | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,098,495 | September 1, 2021 | July 31, 2026 | STEPHEN, CHRISTOPHER D | reporter.nih.gov |
| Gut-brain axis in Parkinson's disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,093,005 | July 1, 2020 | June 30, 2027 | SUBRAMANIAN, THYAGARAJAN | reporter.nih.gov |
| The role of lysosomal impairment in trichloroethylene induced Parkinsonian neurodegeneration | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,086,866 | February 25, 2024 | December 31, 2028 | DE MIRANDA, BRIANA | reporter.nih.gov |
| Neurophysiology of movement transitions in Parkinson's disease with freezing of gait | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,059,572 | September 1, 2024 | May 31, 2029 | HUFFMASTER, SOMMER L | reporter.nih.gov |
| Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,053,052 | April 1, 2016 | January 31, 2024 | WANG, YI | reporter.nih.gov |
| Continuous wearable monitor for the detection and release of Freezing of Gait | NIH | National Institute on Aging | 2021 | $1,044,365 | September 15, 2017 | May 31, 2025 | CONDON, JOHN PAUL | reporter.nih.gov |
| CRCNS: US-France-Israel Research Proposal: A personalized approach to brain stimulation | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2024 | $1,042,872 | September 30, 2020 | June 30, 2026 | LEE, JIN HYUNG | reporter.nih.gov |
| Genetic Silencing of Striatal CaV1.3 Calcium Channels as a Potent Antidyskinetic Therapy for PD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,036,735 | September 30, 2018 | May 31, 2024 | STEECE-COLLIER, KATHY | reporter.nih.gov |
| LRRK2 in Parkinson's Disease Neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,034,567 | January 15, 2022 | December 31, 2027 | MARTIN, IAN | reporter.nih.gov |
| PROTEOMIC MAPPING OF PATHOLOGICAL INTERACTIONS ACROSS THE SYNUCLEINOPATHY BRAIN | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,027,000 | August 15, 2022 | November 30, 2025 | KILLINGER, BRYAN | reporter.nih.gov |
| Mechanisms of spreading proteinopathy in Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,026,156 | September 15, 2021 | August 31, 2027 | UNNI, VIVEK | reporter.nih.gov |
| Impact of Dysfunctional BDNF on Dopamine Terminal Remodeling in the Parkinsonian Striatum | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,024,635 | January 1, 2019 | December 31, 2023 | STEECE-COLLIER, KATHY | reporter.nih.gov |
| The role of the free energy landscape in Parkin's function and dysfunction in health and disease | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,022,433 | March 1, 2020 | February 28, 2025 | WAND, A. JOSHUA | reporter.nih.gov |
| Impact of human disease-causing mutation on striatal synaptic and behavioral plasticity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,019,333 | May 15, 2019 | March 31, 2023 | HUNTLEY, GEORGE W. | reporter.nih.gov |
| A novel gene therapy approach to reduce neurotoxicity in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,009,212 | July 4, 2025 | June 30, 2027 | BRUNDIN, LENA CECILIA | reporter.nih.gov |
| Voice and Speech Sensorimotor Control in Parkinsons Disease | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2022 | $1,006,715 | March 16, 2018 | February 29, 2024 | STEPP, CARA E. | reporter.nih.gov |
| Dieldrin-induced differential gene methylation and parkinsonian toxicity | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,004,112 | January 21, 2021 | August 31, 2022 | BERNSTEIN, ALISON | reporter.nih.gov |
| Microfluidic cell squeezing platform for the transdifferentiation of somatic cells for efficient generation of a cell replacement therapy for Parkinsons Disease | NIH | National Institute of General Medical Sciences | 2022 | $1,001,356 | March 14, 2022 | December 15, 2022 | BRIDGEN, DEVIN | reporter.nih.gov |
| Regulation of lysosomal potassium channels | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,001,049 | April 1, 2019 | March 31, 2029 | REN, DEJIAN | reporter.nih.gov |
| Simple, Home-use, neurostimulAtion tReatment for Parkinson's disease dEmeNtia (SHARPEN) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $994,322 | July 15, 2023 | April 2, 2025 | FOSTER, KRISTEN KATHLEEN | reporter.nih.gov |
| Alpha-Synuclein Assemblies and Metal-Mediated Redox Mechanisms | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $989,164 | September 23, 2019 | July 31, 2025 | LUCAS, HEATHER R | reporter.nih.gov |
| Chaperone-mediated Autophagy and Synaptic Dysfunction in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $986,946 | August 1, 2018 | May 31, 2023 | MAO, ZIXU | reporter.nih.gov |
| LRRK2 and Oxidative Stress in Parkinson’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $981,320 | August 23, 2024 | July 31, 2028 | GREENAMYRE, J TIMOTHY | reporter.nih.gov |
| Discovery of Chemical Factors in the Gut Microbiome that Control Alpha-Synuclein Aggregation in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $973,617 | September 1, 2024 | August 31, 2029 | BESS, ELIZABETH NANCY | reporter.nih.gov |
| Investigating Inhibitory Control Networks in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $964,696 | April 1, 2021 | March 31, 2026 | BENTLEY, JESSICA NICOLE | reporter.nih.gov |
| Towards Generating a Multimodal and Multivariate Classification Model from Imaging and Non-Imaging Measures for Accurate Diagnosis and Monitoring of Dementia in Parkinsons disease. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $956,383 | September 1, 2020 | September 30, 2022 | MISHRA, VIRENDRA R | reporter.nih.gov |
| Selective autophagy in Parkinson'sdisease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $950,899 | July 1, 2018 | March 31, 2024 | YAMAMOTO, AI | reporter.nih.gov |
| Role of the endolysosomal pathway in Lewy body dementia - from population genomics to single cells | NIH | National Institute on Aging | 2021 | $949,468 | July 1, 2021 | June 30, 2023 | BRAS, JOSE | reporter.nih.gov |
| Substantia nigra circuits in instrumental action | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $942,223 | September 4, 2024 | August 31, 2029 | HOLLON, NICK GARBER | reporter.nih.gov |
| Regulation of Dendrite Homeostasis by PINK1 and PKA in Models of Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $937,155 | April 1, 2018 | March 31, 2024 | DAGDA, RUBEN K | reporter.nih.gov |
| Structures and biological activity of alpha-synuclein aggregation | NIH | National Institute on Aging | 2021 to 2023 | $933,114 | August 15, 2019 | April 30, 2024 | JIANG, LIN | reporter.nih.gov |
| Toward a speech rehabilitation model for linguistically and culturally minor groups: Foreign born immigrants | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2025 | $932,094 | March 1, 2023 | February 28, 2027 | KIM, YUNJUNG | reporter.nih.gov |
| Pesticide-Mediated Generation of a Toxic Neurotransmitter Metabolite | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $927,227 | September 30, 2018 | August 31, 2024 | DOORN, JONATHAN A | reporter.nih.gov |
| The Nigral Molecular Clock and Vulnerability to Neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $924,485 | July 15, 2018 | April 30, 2024 | GAMBLE, KAREN L | reporter.nih.gov |
| Oscillatory Neural Correlates of Motor Phenotypes in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $910,626 | September 1, 2022 | July 31, 2028 | INCE, NURI FIRAT | reporter.nih.gov |
| Gut-brain axis in Parkinson's disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $908,901 | July 1, 2020 | June 30, 2022 | SUBRAMANIAN, THYAGARAJAN | reporter.nih.gov |
| a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $901,300 | September 1, 2001 | May 31, 2023 | RISSMAN, ROBERT | reporter.nih.gov |
| Development of High-Speed and Quantitative Neuro MRI Technologies for Challenging Patient Populations | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $857,446 | July 1, 2018 | March 31, 2025 | CHEN, NAN-KUEI | reporter.nih.gov |
| RNA Targeted Drug Discovery and Development for Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $851,067 | June 1, 2021 | May 31, 2023 | MOURADIAN, M. MARAL | reporter.nih.gov |
| The Role of SYNJ1 in Dysregulating the Basal Ganglia Function | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $845,248 | September 15, 2019 | May 31, 2023 | PAN, PING-YUE | reporter.nih.gov |
| Slow wave sleep as a biomarker of rehabilitation-induced cognitive improvement in Parkinson's disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $843,021 | April 1, 2021 | October 31, 2022 | AMARA, AMY WILLIS | reporter.nih.gov |
| Alpha-Synuclein Induced Network Hyperexcitability in Lewy Body Dementias | NIH | National Institute on Aging | 2021 | $840,282 | September 30, 2021 | August 31, 2023 | VOSSEL, KEITH ALAN | reporter.nih.gov |
| Effect of agent and host factors on alpha-synuclein strain pathogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $839,348 | January 15, 2022 | December 31, 2026 | WOERMAN, AMANDA L. | reporter.nih.gov |
| Alpha-synuclein Regulates Dopamine Transporter Functions | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $834,074 | September 15, 2010 | July 31, 2024 | KHOSHBOUEI, HABIBEH | reporter.nih.gov |
| Pathological and cognitive correlations of real time quaking induced conversion in LBD and AD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $828,489 | July 15, 2021 | June 30, 2027 | COUGHLIN, DAVID G | reporter.nih.gov |
| Integrating pathogenic mechanisms in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $822,378 | June 15, 2018 | May 31, 2024 | SWANSON, RAYMOND A | reporter.nih.gov |
| An in vivo multiplex model to study gene-environment interaction in Parkinson's Disease | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $809,767 | July 1, 2023 | June 30, 2026 | SARKAR, SOUVARISH | reporter.nih.gov |
| Uncovering the neurophysiology of motivation in ParkinsonÃÂs disease with implanted adaptive brain stimulation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $809,112 | March 1, 2021 | February 28, 2025 | LITTLE, SIMON | reporter.nih.gov |
| DiSCERN: Advanced PD Therapy Candidacy and Evaluation System | NIH | National Institute on Minority Health and Health Disparities | 2021 | $802,719 | September 20, 2018 | June 30, 2024 | HADLEY, AARON JOHN | reporter.nih.gov |
| Molecular Mechanisms of Tubulin Polymerization Promoting Protein in Mitochondrial Function and Neuronal Survival | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $795,678 | July 1, 2024 | June 30, 2029 | BANERJEE, SWATI | reporter.nih.gov |
| Determining the mechanism of alpha-synuclein dependent innate immune responses in the brain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $794,078 | April 1, 2022 | June 30, 2023 | BECKHAM, JOHN DAVID | reporter.nih.gov |
| Changes in synaptic vesicle-binding of alpha-synuclein as an early biomarker for synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $793,535 | December 1, 2024 | November 30, 2029 | BURRE, JACQUELINE | reporter.nih.gov |
| The Role of Alzheimer's Disease Genetic Risk in Predicting Parkinson's Disease Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $793,430 | September 15, 2020 | June 30, 2025 | TROPEA, THOMAS FRANCIS | reporter.nih.gov |
| Neuroplasticity and the emergence of motor and cognitive deficits in prodromal synucleinopathy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $787,249 | August 15, 2022 | July 31, 2027 | MACKINNON, COLUM D | reporter.nih.gov |
| Contribution of transcriptional mutagenesis of oxidative DNA lesions to generatingnew mutant alpha-synuclein species and aggregation toward the pathogenesis of Parkinson'sdisease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $785,000 | May 15, 2018 | April 30, 2024 | KIM, YOON-SEONG | reporter.nih.gov |
| The Impact of Beta- and Gamma-Synucleins on Alpha-Synuclein's Synaptic Function | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $783,258 | April 15, 2022 | March 31, 2027 | BURRE, JACQUELINE | reporter.nih.gov |
| Neuron death in Parkinson's disease: The role of Trib3 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $782,774 | June 1, 2012 | December 31, 2023 | GREENE, LLOYD A | reporter.nih.gov |
| Imaging Epigenetic Mechanisms in the Lewy Body Dementias with [11C]Martinostat | NIH | National Institute on Aging | 2021 | $776,355 | September 30, 2021 | August 31, 2023 | GOMPERTS, STEPHEN N. | reporter.nih.gov |
| Cognitive and Affective Network Dysfunction and Neuromodulation in Aging and Synucleinopathy | NIH | National Institute on Aging | 2021 to 2025 | $772,200 | May 1, 2021 | April 30, 2026 | BURNS, MATTHEW ROBERT | reporter.nih.gov |
| Efficacy and Mechanisms of a Metacognitive Strategy Intervention for Parkinson disease-related Cognitive Decline | NIH | National Institute on Aging | 2025 | $771,627 | September 1, 2025 | August 31, 2030 | FOSTER, ERIN | reporter.nih.gov |
| Development and testing of Carbon Quantum Dot architectures to arrest neurotoxicant-insult- related outcomes | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $769,011 | August 1, 2022 | June 30, 2027 | NARAYAN, MAHESH | reporter.nih.gov |
| Cortical-Subcortical Network Dynamics of Anesthesia and Consciousness | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $766,805 | April 1, 2020 | December 31, 2025 | POURATIAN, NADER | reporter.nih.gov |
| Novel Re-engineered L DOPA Probiotic Therapy for Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $765,114 | September 1, 2021 | August 31, 2025 | KANTHASAMY, ANUMANTHA GOUNDER | reporter.nih.gov |
| Dissecting the Etiology of The Lewy Body Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $764,836 | May 1, 2022 | April 30, 2027 | FINKBEINER, STEVEN M | reporter.nih.gov |
| Enhancing Cognitive Resilience In Parkinson's Disease: Role Of Antiaging Protein Klotho | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $760,801 | September 1, 2022 | August 31, 2027 | LUTHRA, NIJEE | reporter.nih.gov |
| Prion and non-prion induction mechanisms of alpha-synuclein pathology | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $759,146 | September 15, 2018 | June 30, 2025 | GIASSON, BENOIT I | reporter.nih.gov |
| The Role of a Neural Mechanism for Inhibitory Control in Cognitive Flexibility | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $756,864 | April 1, 2018 | March 31, 2024 | WESSEL, JAN R | reporter.nih.gov |
| The functional role of MAST1 in mediating a-synucleinopathies and related dementia | NIH | National Cancer Institute | 2021 | $749,756 | February 10, 2020 | December 31, 2021 | JIN, LINGTAO | reporter.nih.gov |
| Mapping neurochemical activity of the basal ganglia in pathological behaviors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $747,000 | August 1, 2018 | June 30, 2025 | SCHWERDT, HELEN N | reporter.nih.gov |
| ASC oligomerization and transmission as an initiating event for protein aggregation in Synucleinopathy Dementias | NIH | National Institute on Aging | 2022 to 2024 | $746,997 | September 1, 2022 | August 31, 2025 | PANICKER, NIKHIL | reporter.nih.gov |
| Cerebellar TMS for postural instability in progressive supranuclear palsy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $745,023 | May 1, 2022 | April 30, 2027 | DALE, MARIAN LIVINGSTON | reporter.nih.gov |
| Anxiety in Parkinson’s disease: using fMRI to evaluate amygdala networks in the on and off dopamine state | NIH | National Institute of Mental Health | 2025 | $742,576 | July 1, 2025 | April 30, 2026 | PONTONE, GREGORY MICHAEL | reporter.nih.gov |
| Role of presynaptic targeting of alpha-synuclein in the pathogenesis of Parkinson's Disease and Dementia with Lewy Bodies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $742,500 | May 1, 2018 | February 28, 2023 | VOLPICELLI-DALEY, LAURA A. | reporter.nih.gov |
| Pathological striatopallidal neuronalensembles in learned motor impairment in PD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $741,562 | September 1, 2018 | May 31, 2024 | KANG, UN JUNG | reporter.nih.gov |
| Higher Order Convolutional Neural Network for Classification of Lewy-body Diseases and Alzheimers Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $735,100 | February 15, 2022 | January 31, 2027 | VEMURI, BABA C | reporter.nih.gov |
| Cerebellar cholinergic connections as a biomarker of dementia and gait impairment in Parkinson disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $734,434 | March 1, 2022 | February 28, 2027 | MAITI, BAIJAYANTA | reporter.nih.gov |
| Motor cortical circuitry adaptations in experimental Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $729,300 | April 15, 2021 | January 31, 2027 | CHU, HONG-YUAN | reporter.nih.gov |
| Investigating Novel Genetic Variants that Confer Susceptibility to Pesticide-induced Parkinson's Disease | NIH | National Institute of Environmental Health Sciences | 2025 | $728,408 | January 17, 2025 | November 30, 2029 | KAYE, JULIA ANN | reporter.nih.gov |
| Elucidation of mitochondrial mechanisms critical to mediating PFAS neurotoxicity | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $727,893 | April 1, 2023 | March 31, 2026 | SAMMI, SHREESH RAJ | reporter.nih.gov |
| Studying Aggregation in Neurodegenerative Disease Using Synthetic Proteins | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $721,970 | February 15, 2019 | August 6, 2023 | PETERSSON, ERNEST JAMES | reporter.nih.gov |
| Prediction of outcomes for deep brain stimulation using multimodal MRI | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $717,986 | December 1, 2021 | November 30, 2026 | YOUNCE, JOHN ROBERT | reporter.nih.gov |
| Moving Mindfully: A MBSR-Centered Approach to Freezing in Parkinson Disease | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $717,792 | September 15, 2021 | June 30, 2024 | EARHART, GAMMON M. | reporter.nih.gov |
| Single domain antibodies for diagnosis and treatment of synucleinopathies | NIH | National Institute on Aging | 2023 | $717,491 | September 30, 2023 | August 31, 2025 | SIGURDSSON, EINAR M | reporter.nih.gov |
| Immune System Aging in Parkinson’s and Alzheimer’s disease: Epigenetics, biologic aging, and heightened immune states in a population-based study | NIH | National Institute on Aging | 2021 to 2025 | $717,120 | May 1, 2021 | January 31, 2026 | PAUL, KIMBERLY | reporter.nih.gov |
| The role of NOD2/RIPK2 signaling in the pathogenesis of Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $716,406 | July 15, 2018 | April 30, 2024 | KO, HANSEOK | reporter.nih.gov |
| Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients | NIH | National Institute on Deafness and Other Communication Disorders | 2025 | $715,574 | September 1, 2025 | August 30, 2030 | GUENTHER, FRANK H | reporter.nih.gov |
| Changes across the lifespan in the use of heuristics to guide decision-making | NIH | National Institute on Aging | 2021 | $711,784 | May 1, 2019 | October 15, 2021 | BASSO, MICHELE A | reporter.nih.gov |
| Impact of nigral and extranigral neurodegeneration on aerodigestive discoordination in a pesticide model of Parkinson's disease | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $709,261 | September 1, 2024 | June 30, 2029 | GOULD, FRANCOIS | reporter.nih.gov |
| Cellular and Molecular Basis for Cognitive Impairment Associated with Glucocerebrosidase (GBA1) Mutation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $708,750 | September 30, 2018 | January 31, 2025 | TANG, GUOMEI | reporter.nih.gov |
| MC1R Basis of Melanoma-Parkinson's Link and Neuroprotective Potential of MC1R | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $703,272 | April 1, 2018 | March 31, 2025 | CHEN, XIQUN | reporter.nih.gov |
| PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $702,426 | September 30, 2018 | June 30, 2024 | LAVOIE, MATTHEW J | reporter.nih.gov |
| Higher Order Convolutional Neural Network for Classification of Lewy-body Diseases and Alzheimers Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $702,265 | February 15, 2022 | January 31, 2024 | VEMURI, BABA C | reporter.nih.gov |
| IND-enabling studies for cell therapy in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $700,000 | September 20, 2023 | February 28, 2026 | DAADI, MARCEL | reporter.nih.gov |
| In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $699,225 | September 19, 2023 | August 31, 2025 | BEHROUZ, BAHAREH | reporter.nih.gov |
| The Neuroimmune Hypothesis of Paraquat: Connecting the Periphery and Brain | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $696,470 | February 1, 2018 | January 31, 2024 | BLOCK, MICHELLE L | reporter.nih.gov |
| Polo-like-kinase-2-dependent α-Synuclein Serine-129 Phosphorylation: a Physiological RoleDuring Synaptic Activity | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $694,072 | July 15, 2022 | April 30, 2027 | DETTMER, ULF | reporter.nih.gov |
| Pum2-dependent translational regulation of a-SYN near mitochondria and contribution to the pathogenesis of Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $686,876 | September 15, 2018 | May 31, 2024 | KIM, YOON-SEONG | reporter.nih.gov |
| Gene Therapy for Idiopathic Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $686,284 | September 1, 2024 | August 31, 2026 | BOLOTINA, VICTORIA M | reporter.nih.gov |
| A Thermoreversible 3D Manufacturing Platform for Scalable Production of Dopaminergic Neurons for Parkinson's Disease Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $685,839 | August 1, 2021 | January 31, 2024 | MUCKOM, RIYA | reporter.nih.gov |
| Progression Subtyping and Drug Target Identification for Parkinson's Disease with Integrative Machine Learning | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $684,451 | December 1, 2024 | November 30, 2029 | SU, CHANG | reporter.nih.gov |
| Expanding Mentorship and Neuroimaging Expertise in Patient-Oriented Studies of Brain, Behavior, and Age-Related Dementias | NIH | National Institute on Aging | 2021 to 2024 | $684,120 | September 10, 2020 | April 30, 2026 | CLAASSEN, DANIEL OLIVER | reporter.nih.gov |
| Synthetic biology for controlled release | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $683,638 | May 4, 2019 | January 31, 2024 | ELLINGTON, ANDREW D | reporter.nih.gov |
| Theta burst subthalamic nucleus deep brain stimulation for cognitive and motor improvements in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $682,922 | September 18, 2024 | August 31, 2029 | LEE, DARRIN JASON | reporter.nih.gov |
| Theta burst subthalamic nucleus deep brain stimulation for cognitive and motor improvements in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $678,336 | September 1, 2025 | August 31, 2029 | LEE, DARRIN JASON | reporter.nih.gov |
| Cell-based Platform for Gene Delivery to the Brain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $677,159 | March 1, 2018 | November 30, 2023 | BATRAKOVA, ELENA | reporter.nih.gov |
| Evaluating cell type-specific non-dopaminergics as a Parkinson's treatment paradigm | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $676,957 | September 30, 2018 | June 30, 2024 | TADROSS, MICHAEL R | reporter.nih.gov |
| Autophagon: an Autophagy-Functionalizing Gene Therapy Tool for Neurodegenerative Diseases | NIH | National Institute on Aging | 2022 to 2023 | $676,932 | March 15, 2022 | July 31, 2023 | YAKOUB, ABRAAM M. | reporter.nih.gov |
| α-Synuclein strain properties are associated with diagnosis of and progression to Parkinson's disease with dementia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $673,092 | March 1, 2022 | February 28, 2027 | MAO, XIAOBO | reporter.nih.gov |
| The role of microglia in Parkinson's disease cognitive and motor impairment | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $670,600 | January 1, 2025 | December 31, 2029 | MILLS, KELLY ALEXANDER | reporter.nih.gov |
| LRRK in Autophagy Function and Dopaminergic Neuron Survival | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $670,490 | September 15, 2010 | October 31, 2023 | SHEN, JIE | reporter.nih.gov |
| Neural Mechanisms underlying the benefits of Aerobic Exercise in Advanced Parkinson's disease | NIH | National Institute on Aging | 2025 | $665,118 | September 15, 2025 | August 31, 2030 | ALBERTS, JAY L. | reporter.nih.gov |
| Analytical Tools for Light-Initiated Zn2+ Signaling in Neurodegenerative Disease | NIH | National Institute on Aging | 2025 | $661,537 | December 15, 2024 | November 30, 2029 | JOHNSON, MICHAEL A. | reporter.nih.gov |
| Temporal Patterns of Deep Brain Stimulation | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $660,715 | September 30, 2000 | August 31, 2024 | GRILL, WARREN M. | reporter.nih.gov |
| Modulating Inhibitory Action Control Systems With Subthalamic Nucleus Stimulation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $655,492 | January 15, 2018 | December 31, 2023 | VAN WOUWE, NELLEKE C. | reporter.nih.gov |
| Characterization and targeting of a novel pathway promoting Parkinson’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $647,116 | August 15, 2023 | July 31, 2025 | LAWRENCE, DANIEL A | reporter.nih.gov |
| Anti-inflammatory signals and neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $646,104 | September 21, 2023 | August 31, 2025 | CONTI, BRUNO | reporter.nih.gov |
| Examining the role of phosphatidylethanolamine and autophagic disruption in Lewy Body Dementias and Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $642,408 | August 1, 2021 | January 31, 2024 | WITT, STEPHAN N. | reporter.nih.gov |
| NeuroVision™: A Smartphone Application for Neurology and Telemedicine | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $641,779 | July 15, 2022 | February 28, 2025 | SHIWANI, BHAWNA | reporter.nih.gov |
| Exploiting Dopamine Receptor Functional Selectivity as an Approach to Treat Parkinson's Symptoms | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $636,146 | May 15, 2017 | June 30, 2022 | CARON, MARC G. | reporter.nih.gov |
| HBI-002 to Treat Parkinson’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $633,912 | September 20, 2021 | August 31, 2024 | GOMPERTS, EDWARD | reporter.nih.gov |
| Advancing personalized medicine in PD using harmonized multi-site clinical data | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $631,099 | September 30, 2020 | August 31, 2022 | ERTEFAIE, ASHKAN | reporter.nih.gov |
| Glymphatic MR Imaging and Biomarker Discovery in Aging with HIV Infection | NIH | National Institute on Aging | 2025 | $629,712 | September 15, 2025 | August 31, 2027 | MULLER-OEHRING, EVA M | reporter.nih.gov |
| Protein Palmitoylation in Synuclein Pathophysiology | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $626,910 | July 1, 2019 | June 30, 2024 | HO, GARY P. H. | reporter.nih.gov |
| Dysregulation of Histone Acetylation in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $624,231 | July 11, 2023 | June 30, 2025 | SOLDNER, FRANK | reporter.nih.gov |
| Brain Health Equity Research Collaborative | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $617,687 | December 15, 2024 | November 30, 2029 | SHARRIEF, ANJAIL Z | reporter.nih.gov |
| Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease. | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $616,200 | February 1, 2025 | December 31, 2029 | BECKSTEAD, MICHAEL J | reporter.nih.gov |
| Neuroimaging of PDE10A | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $615,283 | September 15, 2017 | August 31, 2024 | PERLMUTTER, JOEL SYNES | reporter.nih.gov |
| Investigating environmental and gene-environment contributors to Parkinson's disease risk by coupling quantitative environmental exposure data to iPSC modeling | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $615,207 | December 1, 2022 | November 30, 2027 | KROLEWSKI, RICHARD CARL | reporter.nih.gov |
| Precision mapping of Parkinson's Disease pathophysiology in the Somato-Cognitive Action Network’s DBS targets | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $613,897 | January 1, 2025 | December 31, 2029 | GORDON, EVAN M. | reporter.nih.gov |
| Determining the mechanism of alpha-synuclein dependent innate immune responses in the brain | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $607,778 | September 2, 2023 | March 31, 2027 | BECKHAM, JOHN DAVID | reporter.nih.gov |
| Rescuing ⍺-synuclein toxicity through neuron-specific enhancement of autophagy | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $605,880 | May 15, 2023 | April 30, 2028 | CHUA, JASON PAUL | reporter.nih.gov |
| Build-up of beta-amyloid in the brain in Parkinson's disease | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $605,764 | July 1, 2022 | December 31, 2026 | INYUSHIN, MIKHAIL | reporter.nih.gov |
| SCH: AI-empowered wearable multimodal sensors (AI-MEDALLION) for noninvasive monitoring | NIH | National Library of Medicine | 2024 to 2025 | $603,985 | September 18, 2024 | August 31, 2028 | ZHANG, CHI | reporter.nih.gov |
| Investigation of non-invasive brain stimulation for the treatment of apathy | NIH | National Institute of Mental Health | 2023 to 2025 | $603,648 | July 17, 2023 | June 30, 2027 | SKLEROV, MIRIAM | reporter.nih.gov |
| Encephalitic viral infection and susceptibility to dopaminergic neurotoxins | NIH | National Institute of Environmental Health Sciences | 2021 | $603,534 | September 20, 2019 | August 31, 2024 | TJALKENS, RONALD | reporter.nih.gov |
| Molecular Mechanisms of Diabetic Retinal Ganglion Cell Dysfunction and Neurovascular Crosstalk in Early Diabetic Retinopathy | NIH | National Eye Institute | 2021 to 2023 | $598,239 | March 1, 2019 | February 28, 2025 | SACHDEVA, MIRA MENON | reporter.nih.gov |
| Feasibility of Objective Measures and Outpatient Washout in Disease-Modifying Trials for Parkinson's Disease | NIH | National Institute on Aging | 2021 to 2025 | $595,536 | June 1, 2021 | May 31, 2027 | HACKER, MALLORY L. | reporter.nih.gov |
| Perception and Production of Speech Timing in Parkinson's Disease | NIH | National Institute on Deafness and Other Communication Disorders | 2025 | $590,026 | September 18, 2025 | August 31, 2028 | FRANKFORD, SAUL | reporter.nih.gov |
| In vitro pharmacology and In vivo neuroprotective effects of CMPI analogues in an optimized Zebrafish model of Parkinsons disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $588,000 | May 20, 2022 | April 30, 2026 | HAMOUDA, AYMAN K. | reporter.nih.gov |
| Genome Wide Analysis of Alpha-Synuclein Neurotoxicity | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $585,729 | September 25, 2017 | June 30, 2024 | FEANY, MEL B | reporter.nih.gov |
| Arousal and Timekeeping in a Mouse Model of Parkisonism (Supplement) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $583,993 | April 1, 2022 | March 31, 2026 | BUHUSI, CATALIN V. | reporter.nih.gov |
| Leveraging invasive recordings and immersive virtual reality to characterize freezing of gait mechanisms in Parkinson disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $578,329 | April 1, 2025 | March 31, 2030 | CROSS, KATHRYN AMY | reporter.nih.gov |
| Novel Systemic Delivery of Peptide-Mediated Anti-Sense Oligonucleotides for Dementia with Lewy Bodies | NIH | National Institute on Aging | 2024 | $578,101 | May 15, 2021 | June 1, 2024 | RISSMAN, ROBERT | reporter.nih.gov |
| Development of selective amyloid-responsive fluorescent probes | NIH | National Institute on Aging | 2025 | $572,646 | June 1, 2022 | May 31, 2027 | YANG, JERRY | reporter.nih.gov |
| Advancing Palliative Care for Older Adults Affected by Neurodegenerative Disease: Parkinsons disease, Alzheimers disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2024 | $568,772 | September 15, 2020 | May 31, 2025 | KLUGER, BENZI M | reporter.nih.gov |
| Speech markers of cognitive impairment in Parkinson's disease | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2023 | $567,618 | March 4, 2019 | February 28, 2025 | SMITH, KARA MICHELLE | reporter.nih.gov |
| Parkinson's disease susceptibility in carriers of lysosomal storage disorder genes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $558,615 | September 19, 2019 | August 31, 2024 | ROBAK, LAURIE A | reporter.nih.gov |
| LRRK2 and oxidative stress in Parkinson’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $556,500 | June 1, 2023 | May 31, 2024 | GREENAMYRE, J TIMOTHY | reporter.nih.gov |
| A multiplexable in vivo perturbation toolkit to identify genes affecting neurodegeneration in a model of synucleinopathy | NIH | National Institute on Aging | 2023 to 2024 | $554,302 | September 30, 2023 | September 29, 2025 | PRZEDBORSKI, SERGE E | reporter.nih.gov |
| Screening for Compounds that Lower Intracellular Alpha-Synuclein Levels | NIH | National Institute on Aging | 2021 to 2022 | $553,315 | May 15, 2021 | April 30, 2024 | JOHN, VARGHESE | reporter.nih.gov |
| Bright light modulation of non-motor symptoms in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $550,736 | December 1, 2016 | November 30, 2023 | VIDENOVIC, ALEKSANDAR | reporter.nih.gov |
| Linking Synucleinopathy and Dysfunction of Olfactory Pathways | NIH | National Institute on Deafness and Other Communication Disorders | 2021 | $544,426 | July 1, 2017 | June 30, 2022 | MOORE, DARREN JOHN | reporter.nih.gov |
| Multi-site DBS with precise timing control focusing on synaptic plasticity | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $539,237 | September 15, 2025 | June 30, 2030 | LUJAN, LUIS | reporter.nih.gov |
| Oscillatory Neural Correlates of Motor Phenotypes in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $536,427 | September 1, 2022 | August 14, 2023 | INCE, NURI FIRAT | reporter.nih.gov |
| Lysosomal dysregulation contributes to HAND | NIH | National Institute on Aging | 2023 | $534,644 | September 1, 2023 | August 31, 2025 | SANTERRE, MARYLINE | reporter.nih.gov |
| Neuron- and Circuit-Specific Mechanisms and Adaptations Regulating Motor Function in Parkinson Disease Models | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $532,141 | July 1, 2009 | July 31, 2022 | KREITZER, ANATOL | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Northwestern University at Chicago | Chicago, IL | 22 | $41 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 32 | $36.6 million | 0 | $0 |
| Washington University | Saint Louis, MO | 26 | $35.6 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 19 | $31 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 23 | $29.1 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 26 | $28.5 million | 0 | $0 |
| Emory University | Atlanta, GA | 23 | $27.8 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 27 | $27.6 million | 0 | $0 |
| University of Florida | Gainesville, FL | 29 | $24.7 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 18 | $24 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 10 | $19.3 million | 0 | $0 |
| Stanford University | Stanford, CA | 11 | $19 million | 0 | $0 |
| Duke University | Durham, NC | 14 | $17 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 13 | $16.2 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 19 | $16.1 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 19 | $15.5 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 14 | $14.9 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 14 | $14.6 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 11 | $14.5 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 10 | $14.4 million | 0 | $0 |
| California Pacific Med CTR Res Institute | San Francisco, CA | 1 | $13.3 million | 0 | $0 |
| Van Andel Research Institute | Grand Rapids, MI | 13 | $13.2 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 6 | $13 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 7 | $12.8 million | 0 | $0 |
| University of Rochester | Rochester, NY | 12 | $12.1 million | 0 | $0 |
| Yale University | New Haven, CT | 15 | $11.8 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 14 | $11.4 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 10 | $10.8 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 9 | $10.7 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 7 | $9.8 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 9 | $9.7 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 12 | $9.1 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 8 | $8.9 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 9 | $8.6 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 6 | $8.5 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 5 | $8.5 million | 0 | $0 |
| Florida International University | Miami, FL | 3 | $7.2 million | 0 | $0 |
| Trustees of Boston University | Boston, MA | 8 | $7 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 2 | $6.4 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 6 | $6.1 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 6 | $5.9 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 5 | $5.9 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 3 | $5.8 million | 0 | $0 |
| Colorado State University | Fort Collins, CO | 3 | $5.5 million | 0 | $0 |
| CND Life Sciences, Inc. | Scottsdale, AZ | 3 | $5.5 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 6 | $5.2 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 2 | $5.2 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 3 | $5.1 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 5 | $4.8 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 4 | $4.7 million | 0 | $0 |
| University of Washington | Seattle, WA | 5 | $4.7 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 5 | $4.6 million | 0 | $0 |
| Purdue University | West Lafayette, IN | 5 | $4.6 million | 0 | $0 |
| Carnegie Mellon University | Pittsburgh, PA | 3 | $4.3 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 5 | $4.3 million | 0 | $0 |
| Rbhs-Robert Wood Johnson Medical School | Piscataway, NJ | 7 | $4.2 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 3 | $4.1 million | 0 | $0 |
| Georgetown University | Washington, DC | 4 | $4.1 million | 0 | $0 |
| Ipaces, LLC | Clifton Park, NY | 1 | $4.1 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 4 | $3.9 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 6 | $3.7 million | 0 | $0 |
| Institute for Molecular Medicine | Huntington Beach, CA | 1 | $3.6 million | 0 | $0 |
| Seattle Inst for Biomedical/clinical Res | Seattle, WA | 3 | $3.5 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 7 | $3.5 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 5 | $3.5 million | 0 | $0 |
| Marine Biological Laboratory | Woods Hole, MA | 3 | $3.5 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 2 | $3.5 million | 0 | $0 |
| Sinopia Biosciences, Inc. | San Diego, CA | 1 | $3.4 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 5 | $3.3 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 6 | $3.3 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 1 | $3.2 million | 0 | $0 |
| Utah State University | Logan, UT | 3 | $3.1 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 4 | $3.1 million | 0 | $0 |
| Sri International | Menlo Park, CA | 2 | $3 million | 0 | $0 |
| Lovelace Biomedical Research Institute | Albuquerque, NM | 2 | $3 million | 0 | $0 |
| Amydis Diagnostics, Inc. | La Jolla, CA | 1 | $3 million | 0 | $0 |
| Neurodex INC | Arlington, MA | 1 | $2.9 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 3 | $2.9 million | 0 | $0 |
| University of Chicago | Chicago, IL | 2 | $2.9 million | 0 | $0 |
| Teachers College, Columbia University | New York, NY | 1 | $2.9 million | 0 | $0 |
| ST. Joseph's Hospital and Medical Center | Phoenix, AZ | 4 | $2.9 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 2 | $2.8 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 3 | $2.8 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 1 | $2.7 million | 0 | $0 |
| Nathan S. Kline Institute for Psych Res | Orangeburg, NY | 1 | $2.7 million | 0 | $0 |
| Texas A&m Agrilife Research | College Station, TX | 2 | $2.6 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 3 | $2.6 million | 0 | $0 |
| Barron Associates, Inc. | Charlottesville, VA | 2 | $2.5 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 3 | $2.5 million | 0 | $0 |
| SUNY at Binghamton | Binghamton, NY | 1 | $2.5 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 2 | $2.5 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 1 | $2.4 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 3 | $2.3 million | 0 | $0 |
| Banner Health | Phoenix, AZ | 1 | $2.3 million | 0 | $0 |
| Translational Genomics Research Inst | Phoenix, AZ | 1 | $2.3 million | 0 | $0 |
| San Diego Biomedical Research Institute | San Diego, CA | 2 | $2.1 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 1 | $2.1 million | 0 | $0 |
| Great Lakes Neurotechnologies | Independence, OH | 2 | $1.9 million | 0 | $0 |
| Automated Imaging Diagnostics, LLC | Gainesville, FL | 2 | $1.9 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 3 | $1.9 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 358 | $184,057,649 | 0 | $0 |
| 2024 | 390 | $194,578,817 | 0 | $0 |
| 2023 | 385 | $205,469,425 | 0 | $0 |
| 2022 | 373 | $191,703,343 | 0 | $0 |
| 2021 | 360 | $176,632,838 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.